Podcasts about Guidant

About Lynne Chou O'Keefe:Lynne Chou O'Keefe is the Founder and Managing Partner of Define Ventures, an early stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B-stage digital health startups (www.definevc.com). Lynne has partnered with entrepreneurs to help them build category-defining digital health companies, such as Livongo (NASDAQ: LVGO), HIMS (NASDAQ: HIMS), Unite Us, etc. Previous to Define Ventures, Lynne's experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins, focused on digital health and connected devices early-stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles, launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development, as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell-side transactions in various industries. Lynne has been named WSJ's Women in Venture Capital to Watch in 2020. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.Things You'll Learn:Define Ventures leverages a founder-centric approach to provide strategic insights and partnerships that empower their portfolio companies with an unfair advantage in the digital health market.With $800 million in AUM and partnerships with about 24 companies to date, Define Ventures has become a significant player in the Silicon Valley startup ecosystem, emphasizing strategic insights and a deep understanding of the healthcare industry.It is important to be a supportive and empathetic partner to founders. Define Ventures offers strategic insights and an 'unfair advantage' by leveraging partnerships with providers, payers, and employers to transform the industry and support founders on their journeys.The striking a balance between growth and profitability with portfolio companies and believes the next 48 months will be dynamic for healthcare ventures.Resources:Connect with and follow Lynne on LinkedIn.Learn more about Define Ventures on their LinkedIn and website. 

La monumentale toile d'Eugène Delacroix retrouve sa place au musée du Louvre après six mois de restauration. Le tableau révèle des secrets jusque-là inconnus. Décryptage de l'œuvre en compagnie de tous les acteurs de cette restauration. Du lundi au vendredi, la rédaction de RTL revient sur un fait marquant de l'actualité avec les reporters, les correspondants et les experts de RTL.

La monumentale toile d'Eugène Delacroix retrouve sa place au musée du Louvre après six mois de restauration. Le tableau révèle des secrets jusque-là inconnus. Décryptage de l'œuvre en compagnie de tous les acteurs de cette restauration. Du lundi au vendredi, la rédaction de RTL revient sur un fait marquant de l'actualité avec les reporters, les correspondants et les experts de RTL.

Tous les jours de la semaine, Europe 1 décrypte trois articles de la presse du jour.

Tous les jours de la semaine, Europe 1 décrypte trois articles de la presse du jour.

In this episode of Medsider Radio, we had a fun chat with Trent Reutiman, CEO of Mercator MedSystems. Trent and his team have developed microinfusion devices with the unique ability to locally and directly deliver targeted therapeutics during catheter-based interventions where mechanical therapy isn't sufficient.  Trent has 25 years of leadership experience in medtech including roles in sales, marketing, and business management with a focus on minimally invasive interventional products for companies like IDEV, ROX Medical, RITA Medical Systems, Guidant, and Cordis.In this interview, Trent talks about the importance of generating data, how to balance commercial efforts with clinical initiatives, and why meticulous management is critical for successful commercialization. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume V. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Trent Reutiman.

This week on the Expert Voices podcast, Randy Wootton, CEO of Maxio, speaks with David Nilssen, CEO of DOXA Talent, and a forerunner of revolutionizing how businesses think about and engage with borderless talent. Randy and David take a look at the intricacies of borderless talent acquisition and the attributes that contribute to the success of a CEO in today's ever-evolving SaaS landscape. They discuss how purpose-driven approaches to outsourcing can bring about positive global change and how talent scarcity, remote work, offshoring, and AI integration are altering the business world permanently. David also talks about the value of peer groups and why you need to invest in your tribe. Quotes“The interesting thing about the Guidant business is that we don't make a tremendous amount of money financing businesses. That's what we're known for. But we actually really try to break even, as you're pointing out, on that particular deal. And then we have tax and accounting, payroll and 401K administration on the back end. And so what's really interesting about that business is that we've figured out a way to acquire a customer, profitably acquire a customer and then provide them with other services that really has no acquisition cost associated with it.” -David Nilssen [30:32]“How do we operate at the edge of our own ignorance? How do we keep learning and how do we have enough humility to ask? Because part of the thing I think as a CEO is people look at you for the answer and sometimes you don't know what the answer is. And so you got to admit that you don't know and then go ask questions of everyone you can. Like what you're describing with learning about subscription businesses and how that model works, is going to help you be a better leader and create a better business.” -Randy Wootton [42:22]Expert Takeaways The talent landscape is being reshaped by four key trends: talent scarcity, the rise of remote work, the necessity of offshoring, and AI advancements.Creating a meaningful employee experience is crucial for retention and productivity, particularly in remote work settings.A focus on 'impact' and 'income' helps secure a sustainable career progression for remote employees, generating value for both the employee and employer.Peer groups provide valuable support for personal and professional growth, benefiting not only business leaders but also their interpersonal lives.Today's CEO: curious and open to learning, embraces their role with humility and has a keen sense of responsibility.Timestamps(01:46) Trends in talent scarcity and remote work(04:31) Challenges and advantages of focusing on SMB and mid-market(10:50) Creating a culture of purpose, leadership, team, client, and career(17:05) The value of career pathing and continuous learning for employees(22:19) Tracking the key metrics(30:38) Investing in your tribe: mentor, coach, peer group, and peer advisory(34:56) How to be a CEO: learning and humility(37:26) EO, peer groups, and investing around you(42:16) Success: curiosity, ownership, and a people-first mentalityLinksMAXIOUpcoming Events

In this episode, Ken Hoyme, a semi-retired product security expert, talks in-depth about his 40-year career focusing on safety-critical systems, which spanned across commercial aviation, aerospace, and medical devices, with a particular focus on medical device security. Ken reflects on the personal impact of his work, and also talks about his continued involvement in the field through consulting, teaching, and volunteering post-retirement. He also discusses troubleshooting solutions, his pride for his family, and his passion for pipe organs. Guest links: https://www.linkedin.com/in/kenhoyme/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 022 - Ken Hoyme [00:00:00] Lindsey Dinneen: [00:00:01] Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:08] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:13] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:27] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:37] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:41] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. [00:00:47] Hello and welcome to The Leading Difference podcast. I'm your host, Lindsey, and I am excited to introduce you to my guest today, Ken Hoyme. Ken is the semi retired former Director of Product security at Boston Scientific. His 40 year career spanned commercial aviation and aerospace and medical devices with specific emphasis on medical device security. In retirement, Ken continues to consult, teach, and volunteer. Welcome, Ken. Thank you so much for joining us today. I'm so excited that you're here. [00:01:20] Ken Hoyme: Thanks, Lindsey I'm happy to be here. [00:01:22] Lindsey Dinneen: Wonderful. If you wouldn't mind just starting off by telling us a little bit about yourself and your background, I would love to hear more about you. [00:01:31] Ken Hoyme: Sure, I'd be happy to. Being semi retired, I have had a career that spans close to 40 years, or actually I think I just passed 40 years about a month ago from when I started working. So I went to grad school, did four years of grad school at the same time my wife was in vet school, so four years of marriage that we were both studying like crazy. I never finished my dissertation on a PhD, so I'm the classic PhD, ADD person. Pretty much my entire career has been spent in safety critical, life critical systems, which has been a fascinating area. You gotta do the right job or people might die. [00:02:08] I started, split 50 /50. My first 18 years was at Honeywell Corporate Research Labs, where I ended up working on various things between integrated circuit projects, but a lot of it was focused on control systems for commercial aircraft, and so building safety critical systems that made the pilot interface to the airplane was fascinating, tough, but interesting problems. [00:02:32] Touched a bit on industrial controls and automotive controls, and then mid career, I got recruited away by former Honeywell folks who had gone to Guidant, medical device company at the time, that was later purchased by Boston Scientific, and where I ended up working initially on cardiac pacemakers and defibrillators and then shifted into remote patient monitoring, and that kind of evolved into more detailed interactions with how security can impact patient safety. [00:03:02] So a large fraction of the last 12, 15 years has been in medical device cybersecurity. Did a brief stint, three and a half years, at a small R&D company doing research on medical device cybersecurity, and then returned to Boston Scientific in 2016 to lead the product security program at Boston Scientific, which is what I was doing when I officially retired. [00:03:25] Lindsey Dinneen: Nice. Okay. So lots of cool twists and turns throughout your career. I wanted to touch on a couple things. The first is, you've actually talked about how one of the running themes was safety and safety critical systems and whatnot. And I'm curious, have you always had an interest or a passion in safety and security. Where did that come from? [00:03:49] Ken Hoyme: Given some of my behavior as a kid, you wouldn't think so. I certainly did my share of foolish things as you grew up. My, my interest in grad school was in computer architecture, kind of a foot between hardware and software, though I was in electrical engineering as a degree. So as I ended up at Honeywell, Honeywell was at that time focused on control systems. And control systems are cyber physical systems, they are computers touching the real world physically. And almost all aspects of cyber physical systems-- which are pervasive and now what's viewed as US critical infrastructure-- there's a safety aspect of whether you're talking about nuclear power plants or oil refining and things that can explode to commercial aviation, automotive. All of those things, if they don't work correctly, the people that are interacting with them that run the risk of being harmed. [00:04:44] So it really was that culture at the original research center of thinking about how you interact with the physical world. And so that really grew that interest. And that was the skill set in doing safety analysis that drew guidance to recruit me because it really was obviously another safety critical environment in cardiac devices. So it was a an early budding interest that was really nurtured by the projects and things that worked on for Honeywell. [00:05:14] Lindsey Dinneen: Yeah, absolutely. And then you obviously continued to grow in your career, you continue to be involved in safety and security. And then you had your stint at Boston Scientific. And I wonder if you could share a little bit more about some of the projects that you worked on that were particularly impactful or just moments that stand out perhaps. [00:05:36] Ken Hoyme: My first project, I knew nothing about things that bled. I had avoided them. In junior high, I had to dissect a frog, I really didn't like it. And so in high school, when you needed to have some science stuff, and I knew I was planning on going toward electrical engineering, I skipped biology and took chemistry and physics. And by working on cyber physical systems, aircraft and automotive and industrial controls, nothing bled, but I also had no pets growing up. [00:06:09] And when I started dating my now wife of 44 years, she had a quarter horse, 4 Shetland ponies, a dog and two cats at a 10 acre hobby farm she had talked her parents into buying so that she could have horses. And as a veterinarian, everything in her life bled, so we really had this difference in backgrounds, but interest in learning from each other. [00:06:35] And so when I first went to Guidant, the company recognized I didn't have that domain knowledge. And so I ended up being put on projects specifically with the goal of rapidly bringing me up to speed. I went to various classes on how the heart works, how you pace it, all the various different things. And I can tell you that the dinner conversation changed considerably as I was starting to learn these things and my wife knew these things. So it was kind of an exhilarating mid career change because of having to learn the domain. [00:07:05] So, because of my safety background, Guidant was working on a new architecture for their pacemakers and defibrillators. And I got put on the redundant safety core, which was a redundant hardware pacemaker and defibrillator. If anything failed in the rest of the device, the hardware would kick in and keep the patient pink. And so I got to work on that, and I ended up with several patents. [00:07:30] And so in 2006 or 7, I believe, my brother in law, my wife's brother, ended up with a viral cardiomyopathy and his ejection fraction was down at 15%. It's normally in a healthy human should be up around 70. He ended up getting a resynchronization defibrillator that I had worked on, as well as being put on the home patient monitor that I had been the lead system engineer in developing. And so that was that first family connection of recognizing that what you're doing is personal. [00:08:04] And a few years back, my now 95 year old mother in law has a pacemaker in her and I have four patents on the technology. So you're recognizing that people that you love and care for are using these things. And the people who get these things are loved and cared for by somebody, so it really becomes a passion of building something that works correctly and is safe. Those kind of things stand out in terms of things that are meaningful. [00:08:29] Lindsey Dinneen: Yeah, of course. Yeah, because when you are able to see the results in real time in real life, by people who you know personally who are affected by it, that's such a full circle moment of just recognizing that what you do isn't confined to this silo. It actually does impact lives. And that's a pretty cool thing to be a part of. [00:08:52] Ken Hoyme: And I crossed over into security. I can recommend the devices that I was involved in developing because I am personally familiar with the level of detail that had been done in terms of securing them. So I don't have fears that my family members or others are going to have hackers going after them, which is a paranoia in the industry. The idea of hacking pacemakers became, as Dr. Kevin said, " sucks the oxygen out of the room." It's theoretically possible, but very difficult to do, compared to devices that might be connected to a hospital network, which are exposed to more. [00:09:24] Lindsey Dinneen: And to that point, if you don't mind sharing a little bit more about how you were able to develop those skills and awareness of the importance of medical device security. I know that you are an expert in this field and there is a lot more education and knowledge these days, but it still seems like something every once in a while that you have to remind people, this is actually a critical thing. Do you mind speaking a bit to that? [00:09:52] Ken Hoyme: I started out as an electrical engineer, but evolved to a systems engineer, particularly working in aviation. I worked on the design of the flight deck of the Boeing 777. And Boeing is the-- at least they used to be, they've lost some of the secret sauce-- but they were the premier system engineering organization in the world. And working on a critical system for an aircraft with the master of system engineering, you start learning the techniques. So my, my evolution into system engineering was very much on the job training, certainly a lot of reading and things that went on at the same time, but it was also interacting with experts. [00:10:31] Similar thing happened when security came along is, I got recruited into Guident because of my safety skills. And then within the first year of being there, Guident was putting a remote patient management system together, which was a bedside monitor for every patient with the radio links to the device links up to a server that would analyze all the data for potential alerts that the physician should know. [00:10:56] The system has more than a million patients on it. So it's a scalable protected health information, all of that. Program Manager on that project understood the importance of the various ilities that sit around system engineering and deal with the development. So he hired in a PhD psychologist to do human centered design and machine interface, he had been dealing with all of those issues. And in the medical device world, user interfaces also touch safety, because if you have confusion and a physician or patient makes a mistake in using something, harm can happen. So it's another branch of safety. And he recognized the security implications of what we were doing and hired in security experts. [00:11:43] And so we had this old grizzled, bearded, absolutely canonical look of a computer geek that had been a chief architect at a company called Secure Computing and had been security. And he was titled our Security Curmudgeon and as Lead System Engineer, I worked with these various groups as we balance the design. And it really was interacting with real experts in this field who had no compunction about correcting me whenever I said anything that was inaccurate. [00:12:15] In that environment, I started absorbing. The methods of doing security and the importance of it and what those kind of, so it really was one of those cool opportunities in your career where you get to a Vulcan mind meld with experts and absorb the information and integrate it with what you know. [00:12:32] Lindsey Dinneen: Yeah, absolutely. And at the time of this recording the FDA has finalized their guidance and I'm curious to know what your thoughts are on that and how you feel it's going to affect everybody moving forward. [00:12:50] Ken Hoyme: It's interesting because both the original pre market guidance and the post market guidance came out relatively quickly. The time between the draft pre market and the issuance of it, I think was just less than a year, which everyone who were involved with guidance has said was light speed for the FDA. And the post market was similar, but they've done a couple of iterations in 2018 and 2022 of drafts. And, was in a meeting earlier today where two of the FDA people who had been working on that were mentioning that in both cases, they got more than 100, 000 comments back to the FDA related to it. [00:13:28] You know, the push by Congress to have it out by October 1st really pushed, I don't think anybody thought that it would be feasible to get it done. And yet they did it. It seems like they have clarified many of the concerns that were still in the 2022 draft, had some clear definitions about things like exploitability. So I think it really will anchor, and everyone is scrambling this week to read it and adapt to what's in there. But, the good news is it's not a giant leap from what they issued in 2022. So it's not going to have everyone doing a 90 or 180 degree turn on what they've already assumed it was heading for. So it's just good to have that out in its definitive form. [00:14:14] Lindsey Dinneen: Yeah, absolutely. And it'll be exciting to see how the industry adapts. [00:14:19] Ken Hoyme: As one example, the Health Sector Coordinating Council had published in 2018, I believe it was, their joint security plan, because the non formal standard, but kind of a guide, particularly helpful for smaller companies for what they need to do, incorporate cybersecurity into their quality system and their development. And a lot has changed, and so we have been working since middle of 2022, this is one of my retirement volunteer efforts that I'm involved in, to bring it up to date. [00:14:54] And there was a real goal for the JSB version 2 to be out by the end of this year. And we were worried about the race condition with the FDA getting their final set pre market guidance out. And so one of the activities now is adapting what we've written in the joint security plan to make sure that it is in sync and in line with the finalized guidance. By getting it out now, we have time over the next couple of months to make whatever changes we need to based on that change. Which will be good, it means when that guide is updated, it will not be anchored in an old guidance, but will properly reflect the new update from the FDA. So it's really great to see them do that. [00:15:38] Lindsey Dinneen: Yeah, absolutely. So circling back to something you mentioned, because I'm curious how you were able to overcome it. You mentioned you hadn't dealt early on in your career with anything blood related and you didn't necessarily want to go after that when you were in college. So how are you able to overcome that and say, "No, this is fine. I'm gonna, I'm gonna make it happen." [00:16:05] Ken Hoyme: Thankfully, I didn't have to personally do any implants. Okay. I didn't have to handle a knife or deal with that and get flashbacks of my frog experience. When I left Honeywell, I thought I was going to retire out of the company. I was in an absolutely great position at the research center. I was invited to the strategic planning sessions for the entire aviation business as a technical expert. Honeywell was bought by Allied Signal, which was quite a culture shift. They were far more prescriptive. You're telling research center, here's what you're going to do rather than asking you to partner with the businesses, determine how to best apply the skills. And the other aspect is because I had become an expert in commercial aviation, I was not learning at the rate that you used to. It's like, you know, a lot of things, you're doing more mentoring than individual personal learning. So when I shifted domains and got hired in because I was a senior fellow at Honeywell, they hired me in at the top technical rank that Guidant had at the time to be competitive. I felt a huge obligation to learn the domain as quick as possible. [00:17:19] I needed to feel like I was providing value. It's just not a good feeling to feel like you're taking a paycheck and not providing something for that. It's just not the way I was raised. And so I really took it on that I needed to learn this domain. And the reality, all kidding aside, is the work in understanding the physiology and the behavior of cardiac devices is really more about electrochemistry and how the muscles work and how arrhythmias occur and how they can be cleared. And so it was more of a learning a new technical domain than really dealing with the bleeding side of it. [00:17:57] Yes, when I was at Honeywell, we had a program where if we were working in the commercial aviation side, we had, it was pre 9/ 11, we had jump seat privileges. So I got to be in the jump seat of aircraft so that you could see how the pilots who use the systems you develop, how they interact with them, just as an experience base. And one of my cool things, just as an aside to talk about, along with the family members using cardiac devices is, I got to jump seat a 777 from Dulles to Frankfort, and that's the aircraft that I did a fundamental invention to enable how the flight deck works. So that was cool to actually see the pilots interact with what you did. [00:18:39] The same thing happened in the cardiac world is you got the opportunity to go and experience implants and see the doctors using and interacting with the devices. Again, part of that system's knowledge of how does the end person, the actual user, use those devices and how do you use that knowledge to get better. So the closest thing you get to bleeding is to watch somebody else do one but I never had to actually directly deal with blood. [00:19:10] Lindsey Dinneen: Okay. That's fair. That's a really good hybrid situation right there. Well, nowadays I understand that you are quote unquote retired, however, you are still quite active. So I would love to hear about your current initiatives and frankly, if you don't mind sharing, why you're still so involved, obviously you care, but I'd love to hear it from your perspective. [00:19:35] Ken Hoyme: So I've always been a bit of a workaholic. I gained a lot of my intellectual stimulation through the people I interact with. When I started a corperate research center, it was 25% PhDs, 50% master. It's a great learning environment because there were brilliant people are all around you. [00:19:52] One of my career advices I've given to the young people is go to a place where you are not the smartest person in the room, surround yourself with people you can learn from. Now you want to have your niche. You want to have something that you feel is your area of expertise that you build, but being or thinking you're the best person in the room isn't necessarily a good learning experience. So, I've always enjoyed interacting with people at various stages in their career. [00:20:20] So when I retired, I don't know how many different serious and semi serious reach outs I had from people asking what I was up to and what I was interested in. It was a dozen or something, but I had been interacting for several years at the company called MedCrypt out of San Diego, a company that focuses on initially tools to help secure medical devices, comes out of the medical device world and tools for software build of materials, things of that nature. And while I'm not a software engineer developing tools, they were also starting to build a service business to work with clients on how to improve their quality system. [00:20:59] When I was at Adventium Labs, that three and a half year stint I did between my two Boston Scientific experiences, along with doing government funded research on medical device security, I also did consulting with companies, and so I had formed a reasonably strong opinion about how you can best organize cybersecurity into a quality management system in a medical device company. And so being able to apply those skills, very lightweight, I've tried to keep my consulting to no more than one day a week so that I still can do some retirement activities. [00:21:36] And Mike Kijewski, who's the CEO of that, I've interacted with him for many years and he had been pursuing me before I retired. So they have some people on staff, two of them are ex FDA. One of their FDA people, Seth Carmody, had written the post market cybersecurity for the FDA and I think he did the first draft of the updated cybersecurity pre market. And then they have another gentleman, Axel Wirth, who I've interacted with for a decade and has written textbooks in the space. And so it was a way to continue where you got to really work with smart people and continue to have that intellectual stimulation that watching TV or picking up whittling doesn't give you. [00:22:16] Lindsey Dinneen: Fair, but those two activities on occasion could be good for your mental health, which we were talking about. So you can have both. You can have both. [00:22:26] Ken Hoyme: So my eldest daughter, when she was going through undergrad, wanted to take a class. She went to Luther College in Iowa, which was a very Scandinavian Norwegian school, and there was a class on Scandinavian whittling. And she really wanted to take it, and she did, but she was going into dental school, and so there was this paranoia about her slicing something important in her hand when she was whittling. She whittled with Kevlar gloves on! [00:22:54] Lindsey Dinneen: Oh! [00:22:55] Ken Hoyme: So there's a certain amount of connection, potentially, between whittling as a hobby and that blood thing that I didn't like, so that hasn't necessarily attracted me retirement hobby. [00:23:04] Lindsey Dinneen: That's a fantastic story. I love that. I wonder, you know, with her whittling skills, did those help her in her dental practice? [00:23:12] Ken Hoyme: She stopped it after undergrad. She also no longer plays the oboe, though she had an oboe scholarship along with her sciences because the finger stretching on the oboe ,she has all of the finger exercises she gets at work and doesn't really think she should be taking the risk of fatiguing it more. And so yeah, being safe in that environment has been important. So I think the thing that actually did the best for her is playing video games. She played things like Mario World, where you're having to constantly in your brain translate going around sphere things and jumping. And that's when you're looking through a mirror and drilling in the back of the mouth, you're constantly doing these translations. And so I'm convinced that all the video games she played growing up really gave her the spatial skills that help, particularly as she took the exams to get in, they do try to assess whether somebody is capable of that before you get into dental school, because you don't want to get in there and start getting into drilling and having somebody who just can't make their brain do that. [00:24:17] Lindsey Dinneen: Thank goodness. [00:24:19] Ken Hoyme: Exactly. [00:24:20] Lindsey Dinneen: That's fantastic. [00:24:21] Ken Hoyme: No wonder why people are afraid of the dentist. Maybe they had one of the bad ones. [00:24:25] Lindsey Dinneen: Right. Yeah, exactly. Oh, my goodness. Oh. [00:24:28] Ken Hoyme: And then I had already alluded to the fact that I'm, I'm doing volunteer work at HSCC on the joint security plan. And then the other thing that I did this last winter, and we'll be repeating this, is I had developed and taught a master's level class in medical device cybersecurity through the University of Minnesota's Technological Leadership Institute. And so after giving it once, they decided to make it a core curriculum for their medical device innovation. So it will be scheduled to be given annually. Things like the FDA keep coming out with new guidances, even while we were giving it last winter, one of the things that would happen each week is, this week, this got replaced. It's kind of this constantly changing environment that happens in this space. [00:25:13] Lindsey Dinneen: It keeps you on your toes and it keeps you learning and growing. I guess that's a great thing. [00:25:18] Ken Hoyme: I can't claim I've been bored. [00:25:22] Lindsey Dinneen: Brilliant. All right. Pivoting just for fun. Imagine someone were to offer you a million dollars to teach a masterclass on anything you want. It can be in your industry, but it doesn't have to be. What would you choose to teach and why? [00:25:37] Ken Hoyme: My first thought might be a master class in how to hide out with somebody's million dollars and not get caught. Being realistic, if I was teaching in my domain, I would probably want to expand out things related to security and safety and how that really is my technical expertise. If I was going to jump out of domain, you know, just something that, might seem off the wall would be a masterclass on the design and physics of the pipe organ. [00:26:09] Lindsey Dinneen: Oh, tell me more. [00:26:12] Ken Hoyme: When I was growing up, I studied the classical organ and sang in choir, was in the all state choir in high school and came out of high school thinking, music major, engineering, music, and I ultimately decided I could do music on an engineer's salary a lot easier than the other way around. And so I had twice been on pipe organ projects at churches I've attended where they brought in and bid and had a pipe organ builder install. So I've been close to that process. When I've been over in Europe, I seek organ recitals. So I've gotten to hear many instruments in Europe that are older than the United States. [00:27:00] And so, yeah, that's always been a passion and fascination of mine because there's such a engineering aspect of that and yet so much of it is musicality. And I've learned a lot interacting and talking with these builders. If I had a million bucks, I would be able to dive deeply into the topic and try to flesh out something that would actually be more comprehensive. [00:27:23] Lindsey Dinneen: Amazing. Okay. So I have to ask you, since you are a pipe organ enthusiast, how do you feel about the fact that there's quite a lot in pop culture of, it's being a vilified instrument, you know, you have the Phantom of the Opera, and there's like a Disney something that has a pipe organ that's a bad character. And how do you feel about the fact that pipe organs are used as villains? [00:27:48] Ken Hoyme: It's always an interesting thing when popular culture adapts something that is so much deeper. As a totally different but slight example, the accordion has always made fun of it. I don't remember how I tripped across it, but there is a very famous organ work by Olivier Messiaen, a French composer, which is-- I think it translates from French to English, "The Epiphany of the Lord." It is a multi-part work related to the Christmas story, and it is incredibly complex, somewhat challenging to listen to, you have to be quite into it. But there is a movement called Du Parmanu, which is, " God Descends and Becomes Us." And it is one of the most bombastic, just these big, huge chords. It's just exciting to hear. [00:28:40] And back 20 years ago, I heard or saw something about a Russian woman who had recorded the entire suite on accordion. And here in the Twin Cities, and it's nationally distributed, but I don't know how many different places, there's a gentleman by the name of Michael Barone who works for Minnesota Public Radio, who for 30 years plus has produced a weekly radio program called Pipe Dreams, all about the pipe organ and that. [00:29:10] So I ended up ordering, because I had a friend who was Russian and was only available on a Russian Amazon kind of equivalent, copies of it and sent a copy to Michael Barone and he actually played an excerpt. I think he did the Du Parmenu section on his radio program. And it's in countries like Russia, the accordion is treated very much differently than in Western countries, where it's more of a polka accompaniment. And so it's different instruments have the different faces, depending on how they're viewed and who's viewing them. So I just tend to look at the mass media view of it as the unwashed heathen. [00:29:48] That said, there is a woman who is bursting onto the scene, she's 26, I think, British, name is Anna Hapwood, and she has been making TikTok videos of her playing the organ, including at the, the Albert Great Hall that they do the BBC proms, and she is popularizing the instrument through her TikTok videos. I think it was CBS Sunday Morning, I saw her interviewed about how she's popularizing the instrument. You never know with the modern media and music distribution, how somebody might reinvigorate interest in something that was viewed as old fashioned before. [00:30:26] Lindsey Dinneen: Yeah, I love that. I love that. And I think it always depends on context. All sorts of instruments, for instance, could be used to be very light hearted and fun or very serious and mysterious. And part of it is just, yeah, are you playing in the major or minor keys? And, all the things that go into it. But anyway, it's just funny because pipe organ, I feel is one of those instruments that is a little polarizing [00:30:50] Ken Hoyme: I understand that. I was warped as a child and the interesting merging there is my father was a serial hobbyist. And when he went into a hobby, he went in 110%. And when I was growing up in my formative years, he was into gardening and breeding his own Asiatic lily types. And we had flowers everywhere and garden clubs would come through and tour the garden. [00:31:23] Then he went cold turkey on it and decided to build him an electronic organ in the basement and he built it from initially a kit and then through other designs that he did. And so I was in fifth or sixth grade with the soldering iron in my hand, helping build this electronic organ. And it was, part of what I view, my dad, his dad died in the Great Depression. He came out of World War II and really had to support his mother and sister, and never really had the money for college-- he would have been a great engineer-- but instead he manipulated my brother and I to both become electrical engineers, and part of it was by these, so part of my interest in organ was also my father's manipulation of getting my brother and I both interested in electrical engineering. [00:32:11] Lindsey Dinneen: Hey, it worked out. I love it. Okay. [00:32:14] Ken Hoyme: My brother has a church organ in his basement, so it took a little heavier with him than it did with me. I enjoy it being played but I don't play it myself anymore [00:32:22] Lindsey Dinneen: Ah, understandable. Well, what is one thing you wish to be remembered for after you leave this world? [00:32:24] Ken Hoyme: Number one would be that I didn't overstay my welcome. I would hope to be remembered that I made lives better, I made lives safer. That attention to detail matter and I worked on things that were significant, that actually had meaning for people's lives. When I moved from Honeywell to Guidant, I said, I used to be worrying on things that if they failed, people might die, 375 people at a time. And then you get into medical devices and now you're working to save their lives, one at a time. I would hope to be remembered that I worked to make a difference and had positive impact on people's lives. [00:33:03] Lindsey Dinneen: Yeah. Of course. Yeah. And then final question, what is one thing that makes you smile every time you see or think about it? [00:33:14] Ken Hoyme: I would have to say my children. Yep. I'm incredibly proud of them. They're both, both professionals, a dentist and an audiologist, they have remarkably snarky sense of humor that I presume they got from their mother. My story on that one was, I was telling my eldest one time, she said something snarky and I said, "Kirsten, you are the queen of snark." And her instant response was, "Yep, broke it, you bought it." But yeah, as you think about what you leave behind in the world, and I'm incredibly proud of them and the things that they've learned. They both secure, use individual passwords on every website and deal with the internet with the sufficient paranoia that they should, so I'm proud of that as well, but yeah. [00:33:57] Lindsey Dinneen: Excellent. Well, It sounds like you raised them right. [00:34:01] Ken Hoyme: They're great kids. They had to live with growing up with their dad being an engineer. [00:34:06] Lindsey Dinneen: Yeah. But it looks like it all worked out beautifully. So I'm very glad to hear all that. Ken, this has been so much fun. I really appreciate you joining me today. It was great to hear about your background and your advice, and I loved especially hearing about some of the little nuances that I wouldn't have gotten to otherwise, like pipe organ interests. So that's fantastic. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thanks so much for choosing that organization to support. And we just wish you continued success as you work to change lives for a better world. [00:34:54] Ken Hoyme: Thanks, Lindsey. I really enjoyed chatting with you. [00:34:57] Lindsey Dinneen: Yeah, same. And thank you so much to our listeners for tuning in. And if you're feeling as inspired as I am right now, I'd love it if you'd share this episode with a colleague or two, and we will catch you next time. [00:35:10] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

On this episode, I was joined by Khaudeja Bano, VP of Quality for Combination Products at Amgen. In this episode, the we discuss the details related to post-market safety reporting for combination products. The conversation extends to the comparison connecting safety and quality, the importance of cross-functional teams for risk management, and the approach towards health hazard assessments. Additionally, they delve into managing product responsibilities, the varied international reporting requirements, and the use of technology for improved efficiency. 00:54 Post-Market Safety Reporting 05:23 Challenges in Post-Market Safety Reporting 07:57 Reporting Databases 10:05 21 CFR Part 4b Guidance 11:50 Managing Product Responsibilities 19:12 Challenges in Handling Platforms 23:10 Understanding Health Hazard Assessment 25:32 International Approach to Reporting Dr. Khaudeja Bano is the VP of Combination Products Quality at Amgen. Executive director of combination product safety. She's held multiple roles at other companies as well like Abbvie, Abbott, and Guidant and is the chair of the Post Market Safety committee for the combination products coalition.

In this episode, Host Tom Salemi learns the Elixir Medical story from CEO Motasim Sirhan, who has spent most of his medtech career developing new vascular implants to prop open previously occluded blood vessels. Sirhan led developing of early version of bare metal stents while at Guidant. He'd go on to start and sell a company that developed another vascular device before pairing with Invus Group to start Elixir Medical in 2005. After a false start, the company is collecting promising clinical data for its DynamX vascular scaffolding system. We'll learn why Sirhan sees this as an leap forward from drug-eluting stents. He also shares stories from his career about taking chances and overcoming fears. This episode is sponsored by DeviceTalks West. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

An all-new episode of the Future of Work Exchange podcast features a conversation with Sara Gordon, SVP of Client Relationships at Guidant Global. Sara and I discuss the continued evolution and impact of the extended workforce, insights into the changing world of work, how automation and technology are revolutionizing talent acquisition, and more.

This week Steve and Yvonne interview Jake Zimmerman of The Zimmerman Firm (http://zimmerman-firm.com/) and Genevieve Zimmerman of MeshBesher and Spence (https://www.meshbesher.com/).   Remember to rate and review GTP in iTunes: Click Here to Rate and Review   View/Download Trial Documents   Guest Bios: Jake Zimmerman Jake Zimmerman has litigated on behalf of plaintiffs whose total recoveries approach a billion dollars. Much of his practice focuses on intellectual property disputes, and on patent litigation and licensing in particular. He has also litigated high-stakes cases on behalf of personal injury plaintiffs and defendants. He was selected as a 2019 Attorney of the Year in Minnesota for his groundbreaking work on behalf of a parent whose son was killed at Sandy Hook. He was again selected as an Attorney of the Year in Minnesota in 2021 for his role in appeals from the Bair Hugger MDL litigation against 3M.  Jake graduated Magna Cum Laude from the University of Minnesota School of Law. He lives in Saint Paul, Minnesota with his wife, Genevieve, and two wonderful children. Read Full Bio Genevieve Zimmerman Genevieve presently serves as court-appointed Co-Lead Counsel for plaintiffs in MDL 2666: In re Bair Hugger Products Liability Litigation. Genevieve was trial counsel in the only bellwether trial. The Bair Hugger MDL includes claims brought by patients who allege the Bair Hugger patient warming system caused deep joint infections following total hip and total knee replacement surgeries. Genevieve is also Co-Lead Counsel for Plaintiffs in MDL 2775: In re Smith & Nephew Birmingham Hip Resurfacing Products Liability pending in the District of Maryland. The MDL includes claims brought on behalf of patients who required revision surgery as a result of defective BHR products. Plaintiffs have successfully defeated a motion to dismiss based on preemption and tried the first MDL bellwether case in July 2021. After a three-week trial, the jury agreed Smith & Nephew was negligent for its false or misleading communications to orthopedic surgeons. Since 2013, Genevieve has served as a court-appointed member of the Plaintiffs' Lead Counsel Committee for MDL 2441: In re Stryker Rejuvenate and ABGII Hip Implant Products Liability Litigation, and is also one of four attorneys appointed to the Settlement Committee for the Stryker MDL, which helped to negotiate a settlement in excess of $1.43 billion. Additionally, in May of 2019, Genevieve was appointed to the Plaintiff's Executive Committee of the 3M Combat earplug litigation MDL. She is one of 14 lawyers appointed by Judge Englehardt to MDL 2740, In re Taxotere, which includes claims brought by women who have suffered permanent baldness as a result of the use of Taxotere. She was court appointed to the PSC for the Biomet MDL in the Northern District of Louisiana, and helps patients suffering from hips made by Smith & Nephew, DePuy, Wright/MicroPort, and Zimmer. Genevieve's past work includes helping heart defibrillator patients after a Guidant recall in 2006. She represented patients who suffered serious injuries and death following the use of the recalled prescription drug Vioxx. She has assisted hundreds of clients in obtaining settlements for defective products including Yaz, transvaginal mesh, hernia mesh, Actos, to name a few. During 2007-2009, Genevieve spent nearly 75% of her time providing pro bono legal services to the survivors and families who lost loved ones as a result of the I-35W Bridge Collapse. The consortium was successful in obtaining recoveries exceeding $75 million. Genevieve serves the community through ongoing pro bono work where she has represented victims of domestic violence seeking to obtain court orders for protection, immigrants seeking to update immigration documents, and high school students seeking protection of their first amendment rights to equal access to school facilities. Genevieve is currently the immediate Past President of the Minnesota Association for Justice, having served on the Board of Governors since 2009, and was proud to receive the “Member of the Year” award in 2012, and the “Star” award in 2021. She is a past member of the Board of Governors for the American Association for Justice. Genevieve has been rated by SuperLawyers as a Super Lawyer since 2014. On a personal note, Genevieve volunteers and raises money for scholarship funds for her alma mater, St. Paul Central High School. In whatever free time she has left, she enjoys travel, skiing, recreational marathons, teaching her kids how to swing a hammer, shovel class five, and cheering for her Minnesota sports teams. Read Full Bio   Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com   Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2

On this episode, I was joined again by Dr. Khaudeja Bano, Vice President of Combination Product Quality at Amgen. On this episode Khaudeja and I discuss: - PMSR and Risk Management - Patient Safety, Pharmacovigilance, Medical Affairs, Clinical Affairs in Medical Device and Pharma companies. - PMSR Regulatory Landscape Globally (Outside of the US) Dr. Khaudeja Bano is the VP of Combination Products Quality at Amgen. Executive director of combination product safety. She's held multiple roles at other companies as well like Abbvie, Abbott, and Guidant and is the chair of the Post Market Safety committee for the combination products coalition.

In this week's episode, we interview Richard Ferrari. Rich is a Co-Founder of De Novo Ventures, which had $650M under management and was one of the premier firms dedicated to Medical Devices and Biotechnology. Rich has raised over a billion dollars for companies he has directly influenced and participated in approximately 1.8 billion dollars in acquisition events. Additionally, and most recently, Rich served as the CEO and Chairman of PQ Bypass, culminating in a successful acquisition to Endologix for $350M. Rich has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters was eventually acquired for $125M by Boston Scientific. Rich also pioneered the off-bump bypass movement via CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery ultimately acquired by Guidant for $350M in November 1999. Rich was a co-founder of CTS and the force that led the company to an initial public offering in only 7 months, the fastest of any medical technology company in history. Additionally, Rich was the co-founder of the MTG Group which developed Ensure femoral closure device which sold to J&J for $100M returning 10x to investors, and also IVS which developed the Star Close and sold to Abbott for $100M also returning 10x to investors. Rich is also the co-founder of Transaortic an integrated femoral sheath and embolic capture system for TAVR procedure which was sold last year to Medtronic. Rich is also co-founder of Tenon Medical an orthopedic device for treating SI-Joint Pain currently trading on NASDAQ under TNON. Rich has been and currently is a board member (Executive Chairman) of Medlumics, S.L., a medical device company founded in 2011; a board member (Vice Chairman) of ABS Interventional; a board member (Executive Chairman) of Heart Beam Inc.; a board member of Biomodex Corporation; a board member of Retriever Medical Inc.; a board member of RMx Medical; a board member of Hawthorne Effect, Inc.; a board member and co-founder of TransAortic acquired by Medtronic; Executive Chairman of Sentreheart acquired by Atricure, a board member of Spinal Modulation sold to St Jude and a board member of Hands of Hope Rich is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida.

On this episode, I was joined by Dr. Khaudeja Bano, Vice President of Combination Product Quality at Amgen. On this episode Khaudeja and I discuss: - Safety function (Drug vs. Device) - 21 CFR Part 4 Subpart B - Specific Post-Market Safety Reporting Expectations - Industry Challenges with implementing PMSR Requirements - Working in Quality with a background in Safety - Self Marketing, Toastmasters and Professional Development Dr. Khaudeja Bano is the VP of Combination Products Quality at Amgen. Executive director of combination product safety. She's held multiple roles at other companies as well like Abbvie, Abbott, and Guidant and is the chair of the Post Market Safety committee for the combination products coalition.

In this episode, Nick Spadea-Anello, Boston Scientific's global president of electrophysiology, will explain how the $1.7 billion paid for Bayliss Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant. We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host. Johnson, of course, brings his insider perspective to Newmarker's Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech's stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well. Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston's acquisition of Bayliss. 5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/ 4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/ 3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/ More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/ 2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/ 1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/

MASTERMIND MINUTES - -ONE GUEST - ONE QUESTION - ONE EXPERT ANSWER in Minutes not Hours Today our Guest is Beegees Hebert Senior Account Manager Beegees came to Guidant in 2011, and since then, she's become a small business financing aficionado. Every day, she puts her superior listening skills to good use to become a true advocate for her clients. As an Account Manager, she's committed to helping individuals identify and deploy the financing solution(s) that will help them reach their short- and long-term goals, making the process to funding as smooth as possible. Beegees also has firsthand knowledge of what it takes to run a small business or franchise. Prior to joining Guidant, she served as the General Manager for a chain of tanning salon franchises, and before that, she was the Sales & Marketing Director for an independent health and fitness business. Today, she uses that experience to relate to clients and provide firsthand advice. Contact Beegees at. https://www.guidantfinancial.com/about-us/contact-us/ Contact Gary at: gary@frangrow.com Visit www.franchisegrowthsolutions.com Visit: www.franchisemoneymaker.com --- Support this podcast: https://anchor.fm/gary5396/support

However, unlike many of his peers, Mariani found his transformational role to be in Japan. Back in 1998, he was a director of finance for Guidant, a maker of cardiovascular medical products that was looking to grow its footprint in a number of markets offshore—including Japan, where it had recently acquired one of its distributor partners. “I gave an immediate, ‘Yes!,'” recalls Mariani, when asked whether there was any hesitation before accepting the offer that would advance him into a vice president of finance position at Guidant's soon-to-be-established Japan subsidiary. Operational experience was one of the incentives that Guidant had promised Mariani, so before long the finance transplant had numerous functional areas within the subsidiary reporting to him, including warehousing and distribution, customer care, IT, legal, and compliance. As functional areas became established and the American company successfully aligned its culture within the international setting, growth became a natural by-product. “I think that when we began, we had about 50 employees in Japan—4 years later, there were more than 300,” reports Mariani, whose Japan career chapter would end in Year 4 when he returned to the States after having been named controller and chief accounting officer for the company. However, upon his return, more than a promotion lay in waiting. “We landed back in Indianapolis on the same day that they passed Sarbanes-Oxley,” remembers Mariani, citing the devilishly complex compliance legislation that would occupy many of his waking hours in the months and years ahead. –Jack Sweeney 

LE tableau du jeune Eugène Delacroix.Cliquez ici pour voir le tableauAuteure des textes : Anne SchmauchDirection Editoriale: Pénélope BoeufVoix : Pénélope BoeufProduction : La Toile Sur Écoute Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Funding is a pretty obvious barrier when it comes to buying a franchise. Lexi Ingraffia from Guidant Financial is here to help    guidantfinancial.com path2frdm.com For more information on starting your own franchise reach out to Wes wes@path2frdm.com 

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

durée : 00:28:46 - Personnages en personne - par : Charles Dantzig - "C'est une femme aux seins nus, c'est un chef. Montée sur une barricade, elle guide le peuple armée d'un fusil à baïonnette & d'un drapeau bleu blanc rouge." Charles Dantzig s'entretient de la liberté guidant le peuple de Delacroix avec Dominique de Font-Réaux, directrice du Musée Delacroix à Paris. - réalisation : Clotilde Pivin - invités : Dominique de Font-Réaulx directrice de la médiation et de la programmation culturelle du musée du Louvre

durée : 00:28:46 - Personnages en personne - par : Charles Dantzig - "C'est une femme aux seins nus, c'est un chef. Montée sur une barricade, elle guide le peuple armée d'un fusil à baïonnette & d'un drapeau bleu blanc rouge." Charles Dantzig s'entretient de la liberté guidant le peuple de Delacroix avec Dominique de Font-Réaux, directrice du Musée Delacroix à Paris. - réalisation : Clotilde Pivin - invités : Dominique de Font-Réaulx directrice de la médiation et de la programmation culturelle du musée du Louvre

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney. We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave. Pharma Editor Brian Buntz also sits in the virtual booth to talk about the new Pharma 50 report compiled by our editorial team. Subscribe today on most major podcast applications

In this 30 minute podcast we speak with Amir Abolfathi, the CEO and Cofounder of uLab Systems, developer of the next generation uSmile system that gives orthodontists control over treatment planning and processes while reducing their lab costs. Amir describes uLab Systems as a company that develops a suite of products for orthodontic tools: aligners, brackets and other hybrid systems. Computational power has increased exponentially, allowing orthos to now use a laptop computer to design treatments on systems like uSmile and then either send specs to the company's manufacturing center or produce in-house with a 3D printer. We also cover important topics like: How AI and machine learning simplifies production and treatment planning technology for orthodontists Addressing pain points that orthodontists face with future technological features Using a products like uLab Systems offers to lower patient costs Amir Abolfathi has over 30 years of experience founding, building, and managing medical device companies. He is currently CEO and Cofounder of uLab Systems, the developer of the next generation uSmile aligner system. Prior to uLab, Amir was a founding member of Tusker Medical which was acquired by Smith & Nephew in 2020. He also was a founding member of EndoTex Interventional Systems and Embolic Protection, Inc which both were sold to Boston Scientific. Amir was the Executive Vice President of Research and Development at Align Technology, creator of Invisalign. He has held various management and engineering positions at Pfizer, Guidant, and Baxter-Edwards and has over 100+ issued patents. For show notes and more: pplpractice.com

Notre rendez-vous hebdomadaire du dimanche nous permet de décrypter une œuvre d’art emblématique en peinture, en sculpture ou encore en musique classique. Aujourd’hui, on s’intéresse à un tableau mythique de 260 x 325 cm : « La liberté guidant le peuple », d’Eugène Delacroix. Il est conservé au musée du Louvre.

As one of the first women to fly the Apache helicopter in the U.S. Army, Polson's career spans almost a decade as an Army officer and attack aviation leader around the globe, as well as five years leading and managing in the corporate sector at Guidant and Microsoft. Polson is committed to leadership for lives that matter. Using dramatic storytelling alongside practical lessons and real- life takeaways, Polson uses her experience in the cockpit and the boardroom to speak and write leading companies and organizations across the country and around the world  to overcome resistance, connect to their core purpose, lead from the heart and commit to courageous ownership under the most challenging conditions. http://www.shannonpolson.com/

Great, informative interview with Shannon Polson, one of the first female attack helicopter pilots in the US Air Force. We discuss her journey, and her new book in which she shares insights from other women who have also broken records and achieved new successes. As one of the first women to fly the Apache helicopter in the U.S. Army, Polson’s career spans almost a decade as an Army officer and attack aviation leader around the globe, as well as five years leading and managing in the corporate sector at Guidant and Microsoft. Polson is committed to leadership for lives that matter. From Apache attack helicopters to the Grit Factor with Shannon Polson Irish Tech News · From Apache attack helipcopters to the Grit Factor with Shannon Polson At age nineteen, Shannon Huffman Polson became the youngest woman ever to climb Denali, the highest mountain in North America. She went on to reach the summits of Mt. Rainier and Mt. Kilimanjaro and spent more than a decade traveling the world. Yet it was her experience serving as one of the Army’s first female attack helicopter pilots, leading two Apache flight platoons– taking one on deployment to Bosnia-Herzegovina– and a line company in Korea, that she learned the lessons of leadership she would take with her for the rest of her life. Where did these insights come from? From her own crucibles of experience – and from other women. Writing The Grit Factor, Polson made it her mission to connect with an elite pack of tough, impressive female iconoclasts who shared their candid stories of combat and career. This decorated slate of leaders includes Heather Penney, one of the first female F-16 pilots who was put on a “suicide mission” for 9/11; General Ann Dunwoody, first female four-star general in the Army; Amy McGrath, first woman Marine to fly the F/A-18 in combat and a 2020 candidate for the US Senate – and dozens of other unstoppable women who got there first, including Polson herself. These women led at the highest levels in the most complicated, challenging, and male-dominated organization in the world. Polson brings these voices together, sharing her own life lessons and theirs with storytelling flair, keen insight, and incisive analysis of current, relevant research. See more on her website and to get her book also. and on her twitter account Shannon Huffman Polson, Speaker, Author, Veteran tweeted: "There were some doors I had to kick down." The Army's first female four-star general shares her insights & lessons in #grit here: #leadership #womenvets More about Irish Tech News and Business Showcase here. FYI the ROI for you is => Irish Tech News now gets over 1.5 million monthly views, and up to 900k monthly unique visitors, from over 160 countries. We have over 860,000 relevant followers on Twitter on our various accounts & were recently described as Ireland’s leading online tech news site and Ireland’s answer to TechCrunch, so we can offer you a good audience! Since introducing desktop notifications a short time ago, which notify readers directly in their browser of new articles being published, over 50,000 people have now signed up to receive them ensuring they are instantly kept up to date on all our latest content. Desktop notifications offer a unique method of serving content directly to verified readers and bypass the issue of content getting lost in people’s crowded news feeds. Drop us a line if you want to be featured, guest post, suggest a possible interview or just let us know what you would like to see more of in our future articles. We’re always open to new and interesting suggestions for informative and different articles. If you would like to be featured in our podcast series drop us a line & don’t forget to sign up for notifications for our latest episodes and follow us on Twitter, Linkedin, SoundCloud, iTunes or your own favourite podcast platform. Contact us, by email, twitter or whatever social media works for you and hopefully, we...

Shannon is a woman of many firsts. Among those high points: She is one of the first women to fly Apache combat helicopters in the U.S. Armed Forces. After nearly a decade as an Army officer and attack aviation leader, and later as a leader and manager in the corporate sector at Guidant and Microsoft, Shannon turned her attention to storytelling, in part through her Grit Project blog and in her forthcoming book. In The Grit Factor: Courage, Resilience and Leadership in the most Male Dominated Industry in the World (2020), Shannon shares her own critical leadership lessons along with candid stories of remarkable female leaders and trailblazers.

Amr Salihieh, President & CEO, Shifamed Amr is a seasoned medical device entrepreneur with over 25 years of experience in the medical device industry. Amr is the founder of Shifamed LLC, a Silicon Valley-based medical device incubator founded in 2009, from which Legacy Portfolio Companies Maya Medical, Kalila Medical, and Apama Medical have successfully exited and through which three additional companies are currently under incubation. Prior to founding Shifamed, Amr founded Sadra Medical, a percutaneous aortic valve replacement company, which was sold to Boston Scientific in 2011 and co-founded Embolic Protection, Inc. (EPI) which was sold to Boston Scientific in 2001. Amr has extensive R&D management experience stemming from his engineering consulting firm, Sobek Medical LLC which he sold to EPI, and from his work at CardioThoracic Systems and Guidant. Amr is either the inventor or co-inventor on >100 granted and >140 published US patent applications. He holds a B.S. in Biomedical Engineering and a B.S. in Electrical Engineering from Case Western Reserve University.

Ep. 101 - Shannon Polson: True Grit Shannon Polson is a true Trailblazer, exemplifying courage, tenacity, and perseverance! She is a native of Alaska and at age nineteen she became the youngest woman ever to climb Denali, the highest mountain in North America. She then went on to summit Mt. Rainier and Mt. Kilimanjaro. She raced long-course triathlons and took journeys to Alaska's Arctic After graduating from Duke University, she entered the military, becoming one of the first women to fly the Apache attack helicopter in the US Army. Her career as an Army officer and attack aviation leader around the globe spans almost a decade. She led two flight platoons and a line company, serving on three continents before joining the corporate world. In addition to her military service, she spent five years leading and managing in the corporate sector, at Guidant and Microsoft. As a dynamic, in-demand speaker, Polson reaches thousands of people a year at major organizations and large public venues on topics related to leadership, courage, resilience, and grit.

Hear how to find your grit and be a better leader!  Shannon Polson was introduced to me through Peter Winick’s Thought Leadership Leverage organization when we were both attending one of Peter's Tuesday lunch hour conversations. I just loved her grit and her personal story, and felt it was important to share it. Shannon was one of the first women to fly Apache helicopters, then became a writer, and now she is developing a program to help women create their own “True Grit.” Believing that conversations, words and books can change the way we see each other and actually change the world, she has made it her job to inspire and transform. We join with her in her mission. Please make sure you listen in. To watch our conversation, click on the image below Inspiring other leaders in ways she would have liked to be inspired herself What I particularly like about Shannon is how she uses storytelling to help people develop the skills they need to become better leaders, find their creative solutions, and overcome the ingrained resistance to change which so many of us exhibit. What would it take for your people to connect to their own sense of grit? As one of the first women to fly the Apache helicopter in the U.S. Army, Shannon Polson's career spans almost a decade as an Army officer and attack aviation leader around the globe, as well as five years leading and managing in the corporate sector at Guidant and Microsoft. Today, Shannon uses her experience in the cockpit and the boardroom to speak to major companies and organizations around the world to overcome resistance, connect to their core purpose, lead from the heart, and commit to courageous ownership under the most challenging conditions. When writing her soon-to-be released book, "The Grit Factor: Courage, Resilience and Leadership in the Most MaleDominated Organization in the World,"  Shannon connected with fellow trailblazing women who shared with her their candid stories of leading at the highest levels in the most complicated, challenging and male-dominated organization in the world, the U.S. military. Now she devotes herself to speaking, writing and training through the organization she founded, The Grit Institute, whose mission is to inspire leaders at all levels, especially those in transition or navigating change. It is a wonderful, vaulable resource worth investigating for your own team. You can contact Shannon through her website. Want more stories of terrific women leaders? We recommend these: Blog: 3 Ways A Female CEO Built A Successful Business With A Culture of Collaboration Blog: How Women in Leadership Roles Can Finally Change The Workplace  Podcast: Lisa Caputo—Smashing The Myths Of What Women Can Accomplish Additional resources My award-winning book: "On the Brink: A Fresh Lens to Take Your Business to New Heights" Simon Associates Management Consultants website  

The GRIT Factor In this interview, I speak with Shannon Huffman Polson about her new book The Grit Factor. Psychologist Angela Duckworth has defined GRIT as "perseverance and passion for long-term goal". Shannons shares her 3 phase approach in developing GRIT that anyone can adopt to help them achieve more success in life. Enjoy! Guest Bio. Shannon Huffman Polson served as one of the first women to fly the Apache helicopter in the US Army. Her career as an Army officer and attack aviation leader around the globe spans almost a decade. In addition to her military service, she spent five years leading and managing in the corporate sector, at Guidant and Microsoft. She is the author of The Grit Factor: Courage, Resilience, and Leadership in the Most Male-Dominated Organization in the World. As a dynamic, in-demand speaker, Polson reaches thousands of people a year at major organizations and large public venues on topics related to leadership, courage, resilience, and grit. She and her husband, Peter, have two energetic sons.

How are communication, information, and decisions expected to disseminate in future organizations?  Know it all from our special guest, Anupam Prakash (The Guidant Group) in this week's episode.

Joining Medsider Radio for this episode is Beverly Huss, President and CEO of Qool Therapeutics, a development-stage company working on a novel, non-invasive therapeutic hypothermia device for the preservation of tissue following catastrophic events like a heart attack, stroke, or traumatic brain injury.Previously, Beverly was the CEO of Vibrynt, a start-up medical device company dedicated to creating minimally invasive therapies for patients suffering from morbid obesity. Prior to that, Beverly was the President of Guidant Endovascular Solutions (acquired by Abbott), a medical device company focused on the treatment of cardiovascular and peripheral vascular disease.She holds an M.S. in technology management from Pepperdine University, as well as a B.S. in metallurgical engineering from the University of Illinois. Beverly also has a few patents to her credit in the cardiovascular and obesity medical device arenas.With me on this episode is guest host, Norbert Juist, one of the most honest, genuine, and personable people I know. Norbert runs Sales Performance Resources, where he specializes in recruiting for medtech marketing and sales positions. Prior to this, he was a sales rep at Cordis Endovascular, a spine consultant at Synthes, and a sales rep at Ethicon. Interview Highlights with Beverly HussThe origin story of Qool Therapeutics and how Beverly got involved with the company.The clinical trial strategy that Qool Therapeutics is following and the reasoning for it.Beverly’s strategic approach to making a medical device a reality, including the regulatory, clinical, and reimbursement paths that should be considered.Key learnings from Beverly’s time at Vibrynt. The “other R&R”: the importance of resilience and relentlessness when you are raising money for a company.How to get the attention of medical device venture capitalists.Critical lessons Beverly throughout her career at ACS and Guidant.Beverly’s favorite books and how they inspire resiliency.The business leaders and mentors that Beverly most admires.Advice Beverly would give to her 30-year old self.See more...

I chat with David Nilssen of Guidant as I run through my financial use case as to what is going on with the SBA loan program (debacle) and he offers some good advice. Take a listen

Joe Mandato, Managing Director, DeNovo Ventures Joe joined De Novo Ventures as a Managing Director in March 2003. Prior to joining De Novo, Joe served as Chairman of Confer Software, a developer of software used to create efficiencies and streamline processes in healthcare. He also served as President/CEO of Origin Medsystems, a developer of minimally invasive surgical devices for use in general, cardio-thoracic, and ob-gyn surgery, which was acquired by Eli Lilly & Company in 1992 and spun out as one of the units which formed Guidant Corporation in 1995. At Guidant, Mr. Mandato served as a member of the founding management committee and CEO of two of its five operating units, Origin and Heart Rhythm Technology. He also co-founded and served as CEO of Gynecare, a women's health spin-out of Guidant, which was acquired by Johnson & Johnson. Subsequent to his tenure at Guidant, he served as an Entrepreneur-in-Residence at Mayfield Fund, a venture capital firm. Earlier in his career, he was CEO of Ioptex Research, a developer of intraocular lenses used in cataract surgery, which was acquired by Smith & Nephew PLC. He joined Ioptex from Cilco AG in Zug, Switzerland, the Europe, Middle East, and Africa headquarters of a unit of Rorer Group, where he served as CEO. He began his career in healthcare as a Captain in the U.S. Army Medical Service Corps. Joe received his Doctor of Management from Case Western Reserve University, and serves on its Board of Trustees. His research focused on the evolving role of boards in ensuring effective governance. He serves on the adjunct faculty of The University of San Francisco's Graduate School of Management and co-teaches the course Medical Device Innovation at Stanford University. He also serves on the boards of The Institute of International Education and Save the Children. Joe sits on the boards of Axogen, Endogastric Solutions, Facet Solutions, Hansen Medical (NASDAQ: HNSN), InSound Medical, M2 Medical, Tear Science, Inc. and WaveTec Vision Systems.

Key takeaways:Learn about DISRUPTIVE technologies shaping the future of MedtechWhy AI won't take the role of doctorsTools for success from someone with GLOBAL leadership experienceHow working in the medical device industry affects how you see things as a PATIENTAbout Matthias: Mr. Buerger is the Vice President Regulatory Affairs and Quality Assurance EMEA for Zimmer Biomet.  He has a Master's of Science degree in Biomedical Engineering from Marquette University in Milwaukee, WI, as well as a Dipl. Ing. degree in Electrical Engineering from Fachhochschule Dieburg in Germany. In the past Mr. Buerger has had a variety of different management roles in Quality Assurance and Regulatory Affairs for companies including GE, Baxter, Terumo & Guidant. He has also worked as a Quality Management Systems and Operational consultant for Grant-Thornton, as well as spending time as a lead auditor and test engineer for TUV Rheinland, a European Notified Body. Mr. Buerger has spoken at a variety of international conferences, including RAPS, MD&D, ASQ, IEEE and others.  Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.

durée : 00:27:53 - La Grande table culture - par : Olivia Gesbert, Maja Neskovic - Qui se cache derrière l'artiste iconique? Catherine Meurisse, autrice de bande dessinée, caricature une fois de plus, avec respect et admiration, Alexandre Dumas et le peintre de "La liberté guidant le peuple" dans son dernier ouvrage, "Delacroix" (Dargaud, novembre 2019). - réalisation : Eric Lancien, Gilles Blanchard - invités : Catherine Meurisse Autrice de bande dessinée

durée : 00:27:53 - La Grande table culture - par : Olivia Gesbert, Maja Neskovic - Qui se cache derrière l'artiste iconique? Catherine Meurisse, autrice de bande dessinée, caricature une fois de plus, avec respect et admiration, Alexandre Dumas et le peintre de "La liberté guidant le peuple" dans son dernier ouvrage, "Delacroix" (Dargaud, novembre 2019). - réalisation : Eric Lancien, Gilles Blanchard - invités : Catherine Meurisse Autrice de bande dessinée

Amir Abolfathi is co-founder of uLab Systems. He has over 32 years of operating experience in the healthcare industry focused on developing and commercializing cardiovascular devices, dental products, hearing prosthetics, and genomic diagnostics & analytics. Prior to uLab, he founded four other medical device startups since 1995. He was VP of R&D at Align Technology responsible for product development and clinical education during the first six years of Align inception. Prior to Align Technology, Amir held a variety of executive positions at Pfizer, Guidant, and Baxter-Edwards. Amir holds over 100 issued patents. Amir received an MS in Engineering Management from the University of Southern California and a BS in Biomedical Engineering from the University of California, San Diego. Charlie Wen is the cofounder and president of uLabSystems, an AI based software company to enable doctors to create computer assisted treatment solutions in office. A serial entrepreneur, Charlie has cofounded several companies in multiple markets including: OrthoClear, an orthodontic company exit by selling $20M; FourPosition, advanced indoor GPS device, Karegiver, an AI based senior assistant system, Dentul a device distribution company. Charlie is also known as first CTO of Invisalign, built technology to a successful $1B IPO. Prior to Align, Charlie worked for Hollywood, where two movies he worked on nominated for Oscar. Charlie is the inventor of 100+ patents, and won national math award twice in China. Charlie received his BS from University of Science and Technology of China. He received his MS from Caltech focusing on AI research 30 years ago. Dr. Mic Falkel is a class of 1987 graduate of University of the Pacific, Arthur A. Dugoni School of Dentistry in San Francisco, California. After graduation he attended his General Practice Residency at the Veterans Administration Hospital at West Los Angeles and has been in general Practice in Monterey California since 1989. Having experienced frustration with the performance of local anesthetic in his practice, particularly around the frequency of failed anesthetic, delayed onset, injection pain and post-operative discomfort, he began research into the pharmacokinetics of dental anesthetic. Based on this research, Dr. Falkel has developed an alternative new paradigm in anesthetic delivery science for dentistry. Dr. Falkel is the founder of Onpharma Company an anesthetic technology and products company. Dr. Falkel has a position as Assistant Professor in Local Anesthesia at The University of the Pacific, Arthur A. Dugoni School of Dentistry. In 2015 Dr. Falkel helped start uLab Systems, Inc. as the clinical founder.

Beverly Huss, President & CEO, Qool Therapeutics Beverly Huss joined Qool Therapeutics as President and CEO in September 2013. Previously, Beverly was President and CEO of Vibrynt, Inc. a company that developed a novel minimally invasive therapeutic device for treatment of morbid obesity. Prior to this, Beverly was with Santa Clara, California-based Guidant since 1986, fulfilling a variety of executive roles within the company's various medical device divisions. She managed the worldwide Endovascular Solutions business as President and quadrupled worldwide revenues to $150 million for the carotid and peripheral vascular business in four years. Prior to this Beverly held several executive level positions as Vice President of Guidant's Canada and Latin America operations, Vice President of Vascular Intervention Global Marketing and Vice President of the Stent Business Unit where she built the company's coronary stent business, a market leader for 27 of 28 quarters with revenue growth of zero to $1 billion in three years. Earlier in her career, Beverly held engineering positions at both Honeywell Defense Systems Division and Jones and Laughlin Steel. Additionally, she served as chairman of the Silicon Valley American Heart Association and as a senior advisor to Pervasis Therapeutics, a Cambridge, MA based cell therapy company. Beverly holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois. Beverly has several patents to her credit in the cardiovascular, obesity and temperature management medical device areas. In addition to the Qool Therapeutics, Board, Beverly serves the boards of Accuray, Kalera Medical, and Madorra, and the University of Illinois Material Science and Engineering steering Committee and Biomedical Engineering Steering Committee. She previously served on the boards of Surefire Medical, Ulthera, Dade Behring, Inc., Wright Medical Inc., and Artes Medical. She is a mentor in the Stanford University Biodesign Fellowship Program. Beverly was the recipient of the 2013 University of Illinois College Of Engineering Alumni Award for distinguished leadership in the medical device industry.

Dr. Aklog is an adult heart surgeon/entrepreneur and Chairman & CEO of PAVmed Inc. (Nasdaq: PAVM), a multi-product medical device company which he co-founded based in 2014 on a portfolio of five of his own inventions. He previously co-founded Pavilion Holdings Group LLC which created four medical device companies including venture-backed Vortex Medical which developed and commercialized his life- saving invention AngioVac® and was sold in 2012 to Angiodynamics (Nasdaq: ANGO).Dr. Aklog received his AB from Harvard College, graduating Phi Beta Kappa and magna cum laude in Physics and his MD, cum laude, from Harvard Medical School. He completed his general and cardiothoracic surgical training along with a laboratory research fellowship under Dr. Lawrence H. Cohn at Harvard’s Brigham and Women’s Hospital and Boston Children’s Hospital, serving as Chief Resident in Cardiac Surgery at both institutions.Throughout his career Dr. Aklog has been deeply involved in medical device innovation, serving on the advisory boards of many leading medical device companies, including Guidant, Medtronic, St. Jude Medical, and startups.

Kim Rodriguez expected to follow her mom’s career in medicine. But she got bit by the Medtech Bug early and enjoyed a string of sales success at companies of nearly every size including Cocentric, Spectranetics, and Guidant. But three years ago she got recruited to be CEO of a company that was rich in promising technologies as well as business challenges. In just three years, Rodriguez and her team at Acessa pulled out of the tail spin, secured FDA approval and a CPT code and now are building a promising women’s health company. In this episode, she’ll share how aspiring execs should ante up.

Ben Saltzman, MA. is an igniter of human potential, the coaches coach, an internationally known World Class facilitator, shadow dancer, fortune 500 leadership trainer, coach to spiritually minded multi-millionaire entrepreneurs, and designer of the year long Relational Mastery Course for Emerging Leaders.   Ben has a Masters Degree in Organizational Development from John F. Kennedy University where he teaches regularly, he taught seminars in the Enneagram and Transformational Coaching at the Institute of Transpersonal Psychology, and co-founded the Israeli Enneagram Center in Tel Aviv, Israel where he facilitates the master level classes.   Thousands of people from many countries have been through his seminars in the past 20 years. His coaching clients have raised hundreds of millions of dollars for projects that support the environment and social justice causes.   In corporate America he’s passed from CEO to CEO behind closed doors and referred to as “That Magic Coach”   Past clients include: Hewlett Packard, The Gap, Levi Strauss, the United States Airforce, Guidant, Broadview, Intel Corp., Hunt Oil, Exar, BOSCH, The Global Fund for Women, Capricorn Investments, and numerous high profile entrepreneurs.   Join me and learn more about your enneagram type from Ben Saltzman LIVE!   Explore Dr. Morgan’s transformation tribe here:  https://www.drmorganoaks.com/   https://www.instagram.com/drmorganoaks/   http://intuitivewisdompodcast.com

durée : 00:28:34 - Les Pieds sur terre - par : Sonia Kronlund, Elise Andrieu, Charlotte Bienaimé, Delphine Dhilly, Leila Djitli, Rémi Dybowski Douat, Sophie Knapp, Inès Léraud, Bahar Makooi, Pauline Maucort, Olivier Minot, Ilana Navaro, Delphine Saltel, Stéphanie Thomas, Pascale Pascariello, Valérie Borst, Martine Abat, Adila Bennedjaï-Zou, Judith Chetrit, Léa Minod, Léa Veinstein - Au musée du Louvre, devant le fameux tableau de Delacroix, la Liberté guidant le peuple, échos et propos inspirés d'une France en crise. - réalisation : Vincent Abouchar, Philippe Baudouin, Emmanuel Geoffroy, Cécile Laffon, Marie Plaçais, Alexandra Malka, Delphine Lemer, François Caunac

durée : 00:28:34 - Les Pieds sur terre - par : Sonia Kronlund, Elise Andrieu, Charlotte Bienaimé, Delphine Dhilly, Leila Djitli, Rémi Dybowski Douat, Sophie Knapp, Inès Léraud, Bahar Makooi, Pauline Maucort, Olivier Minot, Ilana Navaro, Delphine Saltel, Stéphanie Thomas, Pascale Pascariello, Valérie Borst, Martine Abat, Adila Bennedjaï-Zou, Judith Chetrit, Léa Minod, Léa Veinstein - Au musée du Louvre, devant le fameux tableau de Delacroix, la Liberté guidant le peuple, échos et propos inspirés d'une France en crise. - réalisation : Vincent Abouchar, Philippe Baudouin, Emmanuel Geoffroy, Cécile Laffon, Marie Plaçais, Alexandra Malka, Delphine Lemer, François Caunac

Jonathan (Jon) is co-founder & CEO at MitraSpan —a medical device development company that is exploring minimally invasive mitral valve repair techniques for treating type IIIb functional mitral regurgitation in heart failure patients. Jon's career in medical devices and cardiology began in 1991 in the ultrasound imaging business at Hewlett-Packard Medical Products (now owned by Philips). He worked on engineering challenges related to manufacturing high-frequency ultrasound transducers for both TTE and TEE devices. In 1995, he led the IVUS catheter program, a joint venture first with Boston Scientific and later Guidant. This business was later spun out to Volcano and then recently acquired back by Philips. In 1999, Jon moved to the venture-backed startup world where he has remained for now 20 years first as VP of R&D at Endotex where he focused on the development of a carotid stent. He led this program through successful feasibility studies and pivotal study launch. Following that and FDA-PMA approval, Endotex was acquired by BSX. In 2001, Jon joined TransMedics as VP of R&D and lead development efforts through the successful completion of the first full venture round. Transmedics recently filed for an IPO and is a pioneering company focused on the normothermic, sanguineous, functional preservation of organs for transplantation. Since 2002, Jon has led a succession of development and clinical trial efforts in the structural heart and mitral repair fields. First, at Viacor he served as both VP of R&D and CEO; and later at Harpoon, he helped arrange for the spinout of IP and the securement of initial program funding. Now, at MitraSpan he continues to innovate on potential breakthrough structural techniques.

Guidant Financial - David Nilssen

No, Amy Belt Raimundo didn’t blow anything up. But she knew early on in college that her initial career choice of chemistry wasn’t her true path. Instead, she earned an economics degree, and used insights learned to begin a stint in consulting. Those formative years led her to business school and a job at Guidant. In this podcast, Amy Belt Raimundo explains how asking the right questions at Guidant set her internal GPS toward a career in investing for venture firms, corporates, and now the most prominent healthcare system in the country.

In this episode host Matt Heinz interviews Guidant Financial CEO Dave Nilssen.  They discuss his entrepreneurial journey and an important moment in time when he knew he had to pivot to a new business.  Nilssen describes how his aversion to being sold changed his model for selling Why "cold calling" wasn't an option for his business How he moved from a monthly to a quarterly dashboard for planning How he created “Inbound” lead generation tactics that fill his pipeline  How they created good relevant, creditable content Nilssen talked about the The Pivot which is a process, a moment in time, when it is suddenly clear that the time has come to PIVOT to a new business model The PIVOT can be from one business to another The PIVOT can be from one career or job to another How to analyze the business gap ______________________________ Sales Pipeline Radio is sponsored and produced by Heinz Marketing on the Funnel Radio Channel.  Each week at 11:30 am Pacific time (plus 8 hours UTC Time) Matt Heinz interviews the best and brightest minds in sales and Marketing.  If you would like to be a guest on Sales Pipeline Radio send an email to:  sheena @ Heinzmarketing dot com

Today's episode is the first installment of a new Quiet Light series entitled “incredible acquisitions.” In these features, we'll bring you guests involved in successful acquisitions of Quiet Light listings. This is something we're trying out in order to feed our listeners what they want to hear – so email us your feedback! Today's story is interesting because the buyer made his deal using ROBS. Rollover for business startups (ROBS) allows you to invest retirement funds from a 401(k) or individual retirement account (IRA) into your business without paying early withdrawal penalties or taxes. Rick, the new owner of the website Gunskins, a financial executive looking for another income stream to take him into retirement, knew his stuff and made the decision to make his purchase with ROBS. Today's episode is the soup to nuts of the acquisition process and will be beneficial whether you're doing this for the first or the fifth time. Episode Highlights: The process of searching – how long did it take and what approach did Rick take? The depths of the search process – how far Rick dug into each potential business. When the focus narrowed to selling physical products. How he structured the finance for the purchase. ROBS vs. SBA What was it about this particular business that stood out to Rick. The importance of the person behind the business for sale. How many other business Rick looked at in his multiple range. Whether a buyer should look beyond their multiple range. We (re)stress the importance of due diligence. Rick walks us through the first days of the takeover of the business. The transition process is never easy nor stress-free and escrow agents are key. If he had to do it again, what Rick would do differently. Rick's plans for building out. Staffing changes Rick worked through in transitioning. Rick shares last minute thoughts for buyers and sellers. Transcription: Mark: So a few years ago I had a couple of experts … I had a call with a couple of experts for a way to buy a business called ROBS, right? Roll Over for Business Startups. It's kind of an unknown or pretty little known way of financing a purchase and we mixed up in a lot of red tapes and everything else but is it a viable option to be able to buy a business and run a business and finance that purchase outside of kind of the traditional spend cash or SBA loan. I know you and I are starting up this new series within the Quiet Light Podcast called Incredible Acquisitions. We don't have a great schedule for it yet but this is the first installment of that episode and I'm excited because you've got somebody who made an incredible acquisition thus the name using ROBS. Joe: Yeah absolutely and it's an interesting one because the individual behind the purchase, a guy named Rick. He's about 50 years old; very mature high level CFO in public corporations. So he knows his stuff. He gets the numbers, he understands it. And so it's not a light decision that he decided to go with the ROBS. He was going to do an SBA but he and his wife who's a CPA decided the best approach for them would be a ROB and they purchased GunSkins, closed … I want to say about nine months ago and we talked about his search. We talked about his due diligence process. We talked about his take over, what training and transition was like and now whether or not it's a family run business. Mark: Yeah this Incredible Acquisitions is really everything soup to nuts about doing an acquisition for people that have actually done an acquisition. And hopefully, it'd be able to give some insight especially to first time acquirers or fifth time because there's more than one way to go about this. So I love the fact that this is a family run business not just because I'm a family guy but … his son is doing customer service. Joe: At 14 years old, that's right. It's amazing. Well, he's not going to pick up the phone it's all … let's go back, I launched this business or I was going to launch it. I think I did … maybe I did just before Christmas of '17 and the guy that owned the business was overpaying his brother dramatically and my advice was to let his brother go. [inaudible 00:03:02.7] before Christmas remember that? Mark: Yeah we had … I remember that I called you all sorts of names on the podcast. Joe: You did and so did his brother. He's a predator off the podcast. But we worked it out, we did an adjustment that just was logical mathematical and it made sense. And you know it turned out that the brother stayed on during the transition and training period and then literally the 14 year old spends about five to ten minutes a day doing customer service by just doing … choosing the auto responder in the chat focus … in the chat like itself. It's great. It's a great story and I think it's great to hear buyers talk about their process and what they did to purchase a business and then to have some pretty amazing growth along the way which is a good part of what he talks about. Mark: All right I got a quick message for the listeners here on the podcast. We've been doing this now for about a year and a half if I'm … or actually less than a year and a half but we have a lot of episodes and I spent some time recently going over what you guys have actually listened to and responded to. This Incredible Acquisitions is something that we're trying … a new way to do it, it's not something that we're going to be able to do every week but listen to this episode and send me an email mark@quietlightbrokerage.com. Let me know what you think. Do you want more episodes like this? We're trying to be a bit more intentional this year about the guests that we bring on to be able to feed what you guys want to hear. So let us know is this right up your alley or do you want us to continue bringing on experts to … that specialize in PPC or whatever. We're going to still have some of those guests. Let us know. Let's get into the … today's episode of Incredible Acquisitions from Rick and hear this awesome story. Joe: Hey folks it's Joe Valley from Quiet Light Brokerage and today I have a client on the phone. Actually, it's a buyer. We're starting the Incredible Series in 2019 and this is the first of Incredible Acquisitions. I have Rick on the line. We're not going to actually share Rick's name for confidentiality purposes but Rick how are you today? Rick: I'm doing good Joe. How are you doing? Joe: I'm doing fantastic. We are going to talk about the site that you bought. We're going to share that. We're going to share a lot of information. Let's start first though with a little bit of your background. What was your professional life and what is your professional life now that you own an e-commerce business? Rick: Sure, that's a great question. I graduated from college with a degree in business specifically in accounting. I spent a good chunk of my career working for public accounting firms. And then over the last 15 or so years, I've been a financial executive for mid-sized companies, companies as large as one billion in revenue. Joe: And it sounds like you are about the same age as me. Do you mind sharing how old you are so the folks out there that are in the same boat can— Rick: Yeah, no problem at all. I turned 50 this year so it was a big year for me. Joe: Oh happy birthday in 2018. Good for you. It's a big number that's for sure. All right so you were in the corporate world and at one point you said all right I'm thinking I want to get into the online world, spend a little bit more time with family and friends was that the goal and objective? Rick: Yeah I mean it started off with look I'd like to diversify where my income streams are coming from. And my wife and I over the years have done many, many passive investments in the real estate, in the stock market like many people have. And we're really looking for something that was going to be … that we could be a little more actively involved and engaged with. And at the start, I wasn't at all convinced that I needed to throw my pencil down so to speak and run out of the corporate world. I was just simply looking for another source of income that would keep me active when I wasn't sitting at my desk. Joe: I'm recalling now that your wife is a CPA or something along those lines right? Rick: Yeah. We're both CPA's. We met in world of public accounting and as you might imagine we have a stimulating dinner conversation, CPA things. Joe: Okay so for those out there that own online businesses and are thinking maybe I want to exit someday Rick and his wife are the caliber of buyers that we're going to bring to the table. They're CPA's, they understand financial documents. So as always get your financials in good shape because someone's going to come through them in great, great detail. All right let's jump into a little bit about your process of searching for a business, how long did it take you and what approach did you take? Rick: Yeah, boy it took … I got to think about this, I'm going to say we probably were looking for at least 18 months maybe two years. And you know we started off quite broad and we were looking at everything. Not just e-commerce but also brick and mortar opportunities ranging from franchises to mom and pop businesses etcetera. And as we learned more, we looked at more businesses … and this is something I can't emphasize enough because it's really important to look at a lot of businesses. There's no cost to doing that as a perspective buyer and you learn a ton. You learn how folks are doing things right and maybe how folks are … some things you might want to avoid. And so we looked at a ton of different businesses and ultimately became convinced that the e-com was the way to go for us for a variety of different reasons. I continued to be amazed by the tools and resources that are available to e-commerce businesses and the low overhead, low touch nature of e-commerce businesses and that was really attractive to us. We were real about it, we knew that we weren't just going to buy something and then it was going to magically grow on its own and increase revenues but on the other hand we wanted to use the tools and resources available to run that business as efficiently as possible. Joe: A couple of things there that you're repeating so thank you. I say it all the time I feel like I could put on my hand on my desk or my head occasionally that looking for a long time. Finding a great business … and I think you bought one of the great ones, finding a great one is like looking for a needle in a haystack inside of a ginormous haystack. So it's doubly hard. The more you look at … you looked for a year and a half, the more you look at the more you knew the right fit when it came along and you were able to act quickly. Now when we talk about look at them you're not just looking at the listing online and saying yeah that sounds good or no that doesn't sound good. You're digging in and looking at the full details of a business listing right? All the way down into the financials. Rick: Yeah absolutely and you guys at Quiet Light make it really easy to do that. You sign … I think it's still this way anyway, you sign an NDA on the front end and then as you guys post listings and send out emails or put them on your site all I have to do is click a button to receive that information. And you know I think it's important to have the courtesy to follow up with a broker and let them know what you thought of the business and whether you want to move anything forward. But just the ability and the ease with which you can do that; get the information, look at it, and start to learn about the business and about e-commerce, in general, is amazing. And I'm sure there are some other brokers out there that operate similarly but I found your … Quiet Light's process to be very clean and easy in that regard. You know for a prospective buyer it's … you make it easy to look at businesses which is great. Joe: And just for clarification purposes I'm not paying you to say that or give you any kind of discount on the commission correct? Rick: No that's … not yet maybe we'll circle back to that. Joe: Maybe someday I'll buy you a cup of coffee how is that? At what point did you narrow your focus from everything in the possible entrepreneurial world to physical product e-commerce? Because e-commerce can be a broad term meaning anything sold online but you narrowed in to physical products. At what point did you make that decision? Was it simply because you came from the CPA world and it just made sense and you were comfortable with it and not necessarily SaaS or content development? Rick: Yeah you know … I think that's a good question and I would say that there's a step before that, before I narrowed it to physical products I narrowed it to … initially, I was looking at any and all businesses that had … that were the right size and had the right cash flow that I was looking for. And my first narrowing process was really to say okay, I need … if I'm going to do this it needs to be something I'm actually interested in. And initially we were looking at everything from e-commerce businesses that sold ballet tutu's and the other ones that sold toilet products and so forth and so on and that may well be interesting to somebody, it wasn't that interesting to me. And that's where I said okay I need to narrow this up a little bit and make sure that if I'm going to move forward with something it's something that I actually have some passion around. So that's number one. As far as products it just sort of … I don't know if that was a real conscious decision on my part but we did just sort of gravitate that way and that's what appealed to us. And I would say as we got closer actually to pulling the trigger and moving forward on an LOI we found ourselves looking more and more at product companies. It's just … it's what suited us. Not to say that SaaS or something else isn't something … it's something we would definitely consider but for whatever reason, we just sprinted towards products. Joe: I got you. Well, let me get into the business itself that you bought. But before we get there and talk about that particular business can you … one of the things we always talk about is sort of get all your ducks in a row and you and your wife had determined how you're going to do … how were you going to finance and purchase this business? Can you touch on that briefly? Because we did not do an SBA loan in this situation and it was a little creative. Go ahead and talk about that for just a moment. Rick: Yeah I'm happy to because I think it was a really good solution for us. We actually started thinking … we started down the SBA route. We got SBA approval. You've got a great contact with Stephen Speer at Bank United. He's a great guy and it was a smooth approval process. We are sitting there, we had it ready to go and the more my wife and I started looking at it and thinking about it it's like oh gosh. You know I've been working as an executive for over 20 years and over the years we've put some money into 401K's, both of us and that's sitting there idle or not idle but it's in mutual funds and the stock market and so forth; basically passive investments. And we ran across a program that the IRS created called the ROBS program R-O-B-S and it stands for Roll Over Business Startup. And there's a company … first of all you need an advisor to do this but … and there's a company called Guidant Financial in Bellevue Washington that we worked with that are very professional and have a very good process to kind of help you through a ROBS financing. But essentially what you do is you use your 401K money to purchase the business … the target. And what the real beauty of the ROBS program from my perspective is that one I can take that money that's invested in the stock market that I have less control over, I can put it into a business that I have complete control over and as dividends are paid out or when I exit this business those proceeds go or those dividends go tax free back into our 401K. And we don't get taxed on that until we start going on it for retirement which is outstanding. So it was creative and I'm glad we stumbled upon it. It's been really good for us. Joe: That's a beautiful thing. Mark here at Quiet Light wrote an article on it. So folks if you Google ROBS and Quiet Light Brokerage the article will come up in Google and you'd be able to figure that out and take a look. And of course, you can Google Guidant Financial as well. They're quite well known in the space. Okay so let's talk about this particular business. It's rare in my experience and I've been doing this since 2012 that we get a listing that has a utility patent on it. When this one came across my desk it was kind of special. Not only did it have a utility patent for a SKU that was generating about 40% of the revenues but it also had the majority of the revenue coming from its own Shopify store which is in contrast to what we see with a lot of physical based e-commerce businesses these days when they're selling on Amazon as well. Amazon is just growing so quickly that no matter how much they try to build their Shopify Amazon eats up a larger percentage. So what was it about this listing … and it was called GunSkins. I like to call it stickers for guns. What was it about this one that stood out to you right away? Rick: Well, first of all, we don't refer to them as stickers; they're high quality, high performance vinyl. It's the same vinyl that folks put on the cars and trucks and buses and so forth it's … or in boats too. I have seen boats wrapped. But what it is is it's a protective camouflage wrap for your gun. Now there are products out there like Sera Coat or solutions like hydro dipping that allow you to either camouflage, protect, and or dress up your gun … those guns are your standard black. Both hydro dipping and Sera Coat allow you to do something similar to what we're doing with vinyl. The difference is that those processes are both fairly technical. They're fairly expensive. And they're also basically permanent. So you've got to really like whatever it is or whatever pattern you're putting on your gun because you're going to live with it as long as you own that gun. Joe: Correct. Rick: Our product is a vinyl wrap. It's a 3M vinyl. Again the same vinyl they put on cars, trucks, buses, and etcetera. And it's … so it's a do it yourself solution. Our prices range from 10.99 to a high of 64.99. It could generally be applied in two hours or less to your gun. And getting back to your point Joe the patent … the founder of GunSkins applied for it to receive the patent related to the vinyl kit … the template that he created for the AR15. And we happen to make vinyl wraps for a variety of different guns from pistols, to rifles, shotguns, air fifteen's, AK47's, and etcetera. But he received a patent specific to the AR15 which is pretty cool. And so yeah that's the product. Joe: Was it the product category that stood out or the price point of the business with the discretionary earnings and the multiple or the utility patent or it was the utility patent not the design patent, right? Rick: Yeah that's right. Joe: So was it that that stood out that made you go okay this is what I'm passionate about or maybe the category itself because I believe you're a hunter too, right? Rick: Yeah I mean I'm not necessarily a gun nut. I have many friends who are and there's nothing wrong with that. But yeah I have hunted and shot most of my life and so that was attractive. There was a number of things that were attractive about this business and a number of boxes that this business checked in terms of what I was looking for. We were looking for something that had strong growth potential that had multiple sales channels which this one does. We sell on Amazon. We sell through our own website on Shopify, we have eBay, Walmart, FC believe it or not and so … and they also have multiple SKUs so that's another box. And probably most importantly we were looking for a business that had a good foundation. And by that, I mean that it was built in such a way as to it has got good processes. Processes that are relatively simple but also well documented and scalable. And the other adjective I guess I would add to that is portability. So it was very easy for us … I mean I didn't have any previous e-commerce experience outside of my own experience as a consumer to come in and get our hands around this business, understand it very quickly. That's not to say the learning curve wasn't steep. It was quite steep and we expected that but the founder of the business just did a really good job setting it up. That's the number one biggest factor. You know the other things are boxes I need to check like interesting category and the patent and things like that. But the number one box for us was this thing has good bones to it. We're dealing with a seller that has … that's trustworthy and has high integrity. And by the way, you know … and again I'm not being paid for this but also a broker that has the same characteristics, particularly on your first e-commerce purchase. I think that we could go and find our way a little bit easier now having gone through what we've gone through in terms of the acquisition and running this business that wouldn't be as important. But on the first purchase, I think it's critical. Joe: Yeah. Rick: You feel good about the seller. You got to feel good about the broker. And if you don't I wouldn't do the deal frankly. Joe: I agree. We've got a big thing here at Quiet Light and that is follow your gut. And you've got to. You're putting a great deal of your life savings on the line and you might only have one chance and you want to get it right. So for the business owners out there what Rick is saying is that who you are matters a great deal. You want to get yourself put together. You want to get those financials in great shape. You want to be a professional. You want to be somebody that you would buy a business for. There's a lot more to it than just those gross revenue numbers and trends. The person behind the business is often what I see makes the difference in the sale or not. And believe it or not in a 3.0 multiple to a 3.2 multiple you do make a difference. On that point, though Rick this was a good strong multiple. We went out at 3 ½ times multiple I believe … gosh was there any negotiation on the price? Folks I didn't look this up before we decided to— Rick: [inaudible 00:22:30.4] down just a little bit. But yeah it was a 3 plus multiple. Joe: Yeah I think we went out at 3.5 and it was pretty darn close. We're not going to talk actual numbers. We'll just talk those numbers. We won't talk dollars but did you look at many listings that were in that multiple range before making a decision on this one or did you go oh wow that's high I need to look anyway? What was your initial response to the multiple? Rick: Yeah well my initial response was well that's high and … but it was an interesting business. And as I dug into it it's like okay I mean … and as I started checking off those boxes that I was talking about it's like okay well maybe this is just the [inaudible 00:23:09.8] as I went through the diligence process I could see where there is opportunity. I think that the founder and the owner … he was a brilliant guy. He created this idea. He created this business. He built the foundation but everybody that comes to the table brings with them a different set of skills. And when I was looking at it through my eyes I thought okay well I can do X, Y, and Z, and I think leverage this opportunity that much more. So yeah my initial reaction was that's high. I ultimately got comfortable with it and it was the right deal for us. Joe: Yeah. You know it's the valuation process I think with this particular listing because it was mostly Shopify, 60%, 70% Shopify at the time, they get to own their own customers; more value. It had a three plus year track record; more value. It had a patent and 40% of the revenue came from that SKU that the patent was on; more value. The lower the risk, the higher the multiple and in this case there were multiple conference calls. I cannot recall if there are multiple offers. Again I didn't really prepare for this I just wanted it to be a casual conversation. Rick: You told me there were. Joe: There we go. So you remember I don't. You see I've done 20 deals. And I wouldn't lie I mean the reality is that we're going to be forthright and honest with every single person we work with. So even at that 3.5 my point everyone is that sometimes the first thing you look at is the multiple and then you make your decision and that's not always the best choice. In this case with Rick, you've had what 20% month over month of growth since you bought – Rick: Yeah. Joe: Okay so simple math is … go ahead and double check it up for me but if you've got a business listed at a 4 time multiple you buy it at a 4 time multiple and you've got 25% year over year growth and that sticks after you buy the business you're going to make your money back in 2.7 years. In Rick's case, that's going to go down dramatically because of that 20% month over month growth and the multiple is a little lower than that; that 3.5-ish times maybe a little bit lower. All right so let's talk quickly about due diligence. We only have one snafu in due diligence and that was the question I think about when a business owner writes things off that are personal and they put them down as let's say office supplies which I think was the case here. You being a CPA, your wife being a CPA, you got an export of all of the expenses on the American Express or Visa credit card and literally went down through every expense and said: “Well why is it that this trip to Staples is a personal expense?” Because what we did folks is instead of making Kevin the seller go back and re-categorize every single thing that were office supplies I said okay these are normally personal expenses because Kevin worked from home. If any of you saw the listing and watched the video if you remember Rick I think he was building this house and he shot it on his … we interviewed him and he had his iPhone and he did the circular view and mountains in the distance in the background and yeah it's a beautiful. But very casual work from home, the expenses were clearly mostly personal but we went down through them item by item. Or you and your wife did and we had to work on that negotiation a little bit and we worked it out ultimately. But your due diligence process was pretty thorough right down to that level right? Rick: Yeah it was. And our approach was really to grab the P&L that you and Kevin had put together and go line by line and understand what was in each one of those categories and look at different fluctuations and variances month to month or year over year or quarter over quarter. And there's really two questions you're asking yourself if you do something like that. One is: is there anything here that should be particularly on the expense side? And then the other question is: is there something not here that should be? In other words are there expenses that you would expect to be in this business that you're not seeing anywhere and maybe they financed it personally for whatever reason. And so you're really looking for those two types of anomalies and just asking questions and make sure you understand them. Joe: Right, right for sure. Okay so we got through due diligence, we moved on to the asset purchase agreement and then closed. Can you recall the time it took roughly from the letter of intent to closing with the ROBS program that you were involved with? Rick: You know it wasn't bad. It's like anything in life it comes down to organization both theirs and ours. By theirs I mean Guidant … our advisor that helped us through that process. They have a highly structured organized process. And if you follow their process they will help you be organized as well and it will go pretty smoothly. I would say I think it was … well, I don't remember Joe. I'm going to say 45 days. Joe: That sounds about right you know for … this is in effect to cash deal and not on SBA deals. Cash deals take anywhere from 30 to 45 days to close, SBA you're going to add another 30 to 45 days. You did disappear for a little while on us there. You went silent on me if you recall and that was just an incredible job opportunity for you that you took and had to get that going and relocate briefly and make it work and you still managed to juggle that and due diligence and getting the business closed and eventually take over. So let's talk about that we closed and then there is the training and transition period where generally it's up to 40 hours over the first 90 days after closing. Talk briefly about the first few days and what it was like for you when you went to take over the business from Kevin. Rick: Well sure and just to go back very briefly Joe on what we were struggling with and you said I went silent a little bit on you. That's true and what we are struggling with was gosh this business is big enough and has enough potential is this what we want to commit ourselves to do and forget me going to the corporate job. And I struggled with that and I continue to struggle with that. You know I've been struggling with that last frankly because I think we have a pretty good balance and a pretty good system and cadence going now where I can enjoy doing both. You know helping manage the GunSkins business as well as my corporate CFO job that I have. So that's what we're struggling with and who knows that could change as the business grows or changes or what have you we'll see where that takes us. But in terms of transition, I would say we put a lot into due diligence. If I had it to do over again I would probably be better dialed in on transition and really making sure that it was clear between the buyer and seller and sellers/buyers employees or contractors who was going to do what when it was going to get done and so forth because this isn't a small business it's … I'd say a medium sized e-commerce business. We do about 20,000 orders a year through both our website and through Amazon and there's a lot of moving parts that you got to get transitioned over. Simple stuff like making sure that your postage is going to the right credit card. Making sure you've got seller central transitioned over. Making sure that PayPal is set up correctly under your name etcetera, etcetera. And I would say that … and that's probably my lack of … our lack of e-commerce experience that contributed to being a little less organized as it relates to the transmission. It was with a case where we didn't necessarily know what we didn't know. And so I'd probably spend a little bit more time on that. It went fine it was just … it was a little bit anxious for us because the light bulbs are starting to go on. It's like oh gosh or what about this or what about that, well if we got to do this then we have to do this over here and it was … it ultimately was all seamless but I wouldn't say it was stress free. I mean it was a lot of learning. Joe: There's never a transaction like this that is stress free. There's always a lot of emotion involved. And you know part of the purpose of doing recordings like this is to learn. So look we've been at this for almost 11 years as a brokerage firm and we don't have a transition checklist that should probably or could probably help ease those nerves a little bit. So it sounds like maybe what we can do as a brokerage firm is to have the seller create … and we do this but it's not very formal, a complete list, this is in the asset purchase agreement of course. But a list perhaps in Google Sheets of every item that is going to transfer and during the transition period you're going to check each box and ensure that you've got complete control of it before the asset … before the funds are released. That is the way it works folks. Rick wires funds into Escrow. Kevin transfers all of the assets over to Rick's control. And once Rick has control of all of those assets he informs Escrow … the Escrow agent and they release the funds. But we could formalize that process a little bit but it will never … I'm sorry be stress free and emotion free. That's the biggest challenge in these transactions. It's just … it's a big deal. You're making a big life changing investment, putting your hard earned money … your 401K money on the line and you want to make sure you get it right. So we we're going to make sure it's stress free but obviously, it's not always and cannot always be that way. Rick: Correct. And the other thing I would just add to that Joe is that with a [inaudible 00:33:23.6] it's unrealistic to think that you're going to fund Escrow, transition all these assets over and accounts over in 24 hours and be done. It simply takes longer than that. And part of it is out of the control of both buyer and seller. You're dealing with the different tools and resources and platforms that the company is using out there and it takes time for those folks sometimes to work through their process of transitioning that to a new owner. Joe: Yeah. And that's part of the process and that's why … regardless of the size of the deal, I want Escrow in the middle. I want that money that you've invested safely with an Escrow agent. And for your seller to know that as he transfers control over all the assets that he's money is safely … which is his future money, is safely in Escrow as well. Let's talk a little bit about if you had to do it over again what would you do different? This just business as you say was mid-sized, is it big enough to support you financially so that you can quit the corporate world and never go back and if it's not do you think maybe in hindsight you would have held off and try to buy something bigger or are you really happy with the decision and purchase that you made? Rick: Yeah. You know that's a good topic and I'll go back to some rules we operated under in the corporate finance world [inaudible 00:34:51.0] acquisitions in the corporate world. And [inaudible 00:34:54.5] said that the smaller deals take just as much time and are just as hard to work if not harder than the larger deals. And it's absolutely true. It's something I've always found to be true. And so I would say that my advice would be look do something that is going to be meaningful to you. And by meaningful I mean that the investment is meaningful, the cash flow that the business is going to generate is meaningful. Because if it's not … you know I love playing poker and sometimes you get in a poker game where the stakes are too low and it sort of distorts the game and people don't play the way that they ought to play. It's kind of a similar analogy here where putting up at risk so that it's meaningful to you. You're going to pay attention to it and as it bears fruit it's going to mean something to you because you're going to work hard on it. It's not … there's no free lunch. You're going to put blood, sweat, and tears into it. Make sure it's going to be meaningful when it comes out the other side. Joe: Yeah. Rick: So for us, the dollars that we invested out of our retirement savings were absolutely meaningful; they're significant. They're dollars that I don't want to lose. And moreover, the cash flow that this business generates is meaningful. It has the potential to equal or exceed my earnings as a corporate CFO. So yeah I … and the other thing tying back into what we were talking about earlier is what you'll find is that when you start looking at the larger businesses they generally are … they generally have a better foundation. Joe: Right. Rick: You could get into an e-commerce business on the cheap but I think the probability of getting into one that has a strong foundation like the one that we have that GunSkins has is low. It's lower I should say. You got to be a lot more careful and you are at higher risk that when you start getting into the actual processes, how the business is put together, maybe even the integrity of the seller you just … it's a little messier in my experience. Joe: Yeah for sure there's no question and that's why the multiples go up the larger the business. When you get into six, seven, really 7, 8, 900,000, a million dollars in discretionary earnings it's a larger more well established business and therefore as Rick just said it's lower risk. With lower risk, the multiple goes up. Smaller businesses lower multiple because there is more risk without question. Rick let's talk … we're running a little short on time but I want to talk about what types of things you thought you were going to be doing with GunSkins in terms of marketing channels that worked or didn't work, what surprises there were, and we got an audience of both buyers and sellers and there's people out there that are e-commerce experts that may be able to point you in the right direction in terms of getting this marketing in certain places. So let's talk about what worked and what didn't and what are you're hoping to achieve in terms of marketing channels with the business. Rick: Sure so I would say going into the acquisition and early on in the transition I was absolutely convinced that we needed to aggressively build out our dealer channel, our brick and mortar dealer channel. Not necessarily e-commerce stores but brick and mortar dealers like gun dealers, pawnshops, etcetera. There's thousands of them across the country. I thought well maybe we take a look at big retail as well, big box retail. I wasn't as convinced in that but I was convinced on the gun dealerships and that we needed to invest time in building that out. And I'll tell you … and this is again what I learned pretty quickly is that to build out a dealer network, a dealer channel through brick and mortar stores is labor intensive; labor and cost intensive in a very large way. It takes a lot of boots on the ground to go and knock on all those doors and try and sell that product. And what I learned was the cost per conversion on e-commerce is so attractive, it's so incredibly attractive compared to other sales channels. And if you can build your scale and build your brand through e-commerce the dealers will come to you at least in our case, in our business. Joe: They are finding you now. You're not going out and getting them. Rick: Absolutely. Joe: [inaudible 00:39:34.4] they're finding you. Rick: Absolutely. I mean we love our dealers but I think investing a lot of time and money in trying to grow that channel on its own is a little bit silly. And it surprised me because I didn't think that going in. Where we spent our effort is really reinforcing and building our brand, our brand awareness, and private awareness online through social media, through Google Ad Words, etcetera, through Amazon etcetera, etcetera, blog posts and the like. And what we find is people hear about us … dealers in particular and they come to us. Even some of the online distributors, very well-known online stores for guns and guns accessories have reached out to us and say hey we'd like to talk to you about distributing your product on our site. Joe: Excellent. Rick: And that's the way to build a dealership for our business. You can't go out there and put enough boots on the ground to do it otherwise. Joe: Excellent. One last question we talked about staffing very, very briefly but there were two VA's I believe or virtual assistant or remote contractors. You are here in North Carolina where I am and I believe they're both out west or were out west. Are both of the individuals that were working for Kevin still working for you? Rick: One of them is, one of them is not. The gentleman who's continuing with us we call him … but really he's a lot more that— Joe: You broke up right there. Say that one more time for me what do you call him your? Rick: Graphics genius. Joe: Your graphics genius, okay [inaudible 00:41:09.0]. Rick: It really doesn't do him justice to be honest because not only is he our graphics design guy for our patterns and so forth but he also handles a lot of the e-commerce side of things as well; our website and Shopify and Amazon etcetera. He's invaluable and he probably puts in maybe 20 hours a week something like that. Joe: Okay. Rick: So he's continuing. The other VA that Kevin had handled customer service and social media and we've picked that up on our side. My son believe it or not … my 14 year old son does a fair amount on the customer service side answering customer questions. Joe: Excellent. Rick: And this again goes back to the tools and platforms available to e-commerce businesses. We use in Zendesk on the customer service side; it's spectacular. I mean it makes it so easy and so he's enjoying doing that and making a little bit of money. Joe: That's great. I have to tell a brief story … I mean in talking to Kevin we listed this just before the holidays in 2000— was it seven … '16 right? I forgot. Just before the holidays and the customer service person was Kevin's brother who he loves dearly and here I am going man you are so overpaying a relative. It's crazy what he was paying him; I'm like you need to fire him just before the holidays. And he didn't fire him but we … because it just … it was logical and used logic and math and we made an adjustment in the profit and loss statements for really still overpaying a virtual assistant. We made the cost of the VA probably twice what it would normally cost to put that in as the cost to make the adjustment. Full disclosure put that in black and white right in the package. But he did stick with you for a while and you eventually took it in house which is great because you're saving money on the bottom line and teaching your son some business skills as well. Rick: Yeah I mean he's a great guy by the way and he was doing a great work and was very flexible with us on the transition and so … but yeah ultimately we took that over after about three months I think it was. And it takes probably 20 minutes a day something like that. Joe: Yeah I know okay so he was even more overpaid than I thought. If he's anything like Kevin he is a great guy. Kevin spoke very highly of him and I know he did a good job and the transition and training period Kevin and he worked it out and you worked it out so that he was there for you. Because the last thing you want to do is you have to jump in and take over the role of a contractor when that is not what you're intended to do. Rick: Yeah absolutely and again making sure your seller is trustworthy and is operating with high integrity. And Kevin I can't say enough about, he's an outstanding guy and he did things and handled himself in such a way he cared about the business, he cared about our success in taking on that business and that makes a big difference. He didn't have to be as cooperative as he was but that's just who he is and that makes a difference. Joe: Without a doubt, we'll try to get Kevin on the podcast as part of the Incredible Exits series. Rick: Yeah. Joe: Instead of just the Incredible Acquisitions. Well, listen, man, I'm so happy that you bought GunSkins. I'm excited for you. I'm excited maybe to have you on again as an update and talk about where you were able to take it. I mean you've had it for about a year now and we can do it again in another year. Any last thoughts, any last advice or suggestions you can give people that are considering selling their business and what they should do right, do differently than what you normally see or anybody that's buying a business any last minute thoughts for them? Rick: That's great, for sellers we've touched on it a bit through our discussion but really have yourself organized. Have your processes documented. There are great tools out there that you can use to document your processes. Also, have your financials put together. Both my wife and I are CPA's we use a partner in CapForge bookkeeping here out in Carlsbad, California. They use these Quick Books and they are e-commerce experts. I don't know how they make money with what we're paying them but that is money well spent because they— Joe: Perfect and let me just interrupt and point this set down. I'm pounding my desk people. We have two CPA's who own the business and they still hire an e-commerce bookkeeper. Please, folks please do what Rick is doing and get your books in good order. Okay, I'll stop pounding my desk. Rick: No, look I agree it's cheap and they do [inaudible 00:45:51.7] when you go to exit you're going to have all your ducks in a row and Joe's going to be very happy. He won't have to recreate the financials on the Excel spreadsheet. Joe: And you'll get more money. Rick: Yeah. Joe: You'll get more money. Good books instill confidence in buyers and confidence increases the value in the valuation and the multiple so without a doubt. Well, Rick if anybody has a great idea and wants to reach out to you how would they find you? Rick: Right through the GunSkins site, support@gunskins.com and that email is us as owners and we answer every inquiry we get. Joe: Awesome and for everybody out there that is a hunter or owns a gun of any kind please go to GunSkins.com check it out. Go to the YouTube site, you'll get to see the before and after of lots of different guns. The wraps are very, very cool; camouflage wraps, different seasons for camouflage, and even just the American flag and things of that nature if you want to spice it up a bit. Or if you're female and hunting I think there's even some wraps for females too right Rick? Rick: We're going to be launching some great ones here in the next 30 days. We're launching real tree patterns and those include … there's a tiffany blue camouflage pattern. It's popular with women as well as we have paradise pink barrage in the theme as well. But yeah there's something for everybody also visit our Facebook page. We've got over 70,000 Facebook followers and we'd love to count each one of the listeners as a follower as well. Joe: Fantastic. Rick, thanks for your time. Thanks for being a professional. I look forward to having you back on the show to talk about maybe your incredible exit someday. Rick: Absolutely. Thanks, Joe. I appreciate it. Joe: You bet. Links and Resources: Gunskins.com support@gunskins.com Gunskins Youtube Gunskin's Facebook Guidant Financial Quiet Light ROBS article CapForge Bookkeeping Quiet Light ROBS Article

Ben Saltzman, MA. is “The Coaches Coach” the igniter of human potential, an internationally known seminar facilitator, shadow dancer, fortune 500 leadership trainer, and coach to spiritually minded multi-millionaire entrepreneurs. As a radio personality, he was co-host of the Mind, Body Spirit show. Thousands of people from many countries have been through his seminars in the past 20 years. His coaching clients have raised hundreds of millions of dollars, and invest billions of dollars in projects that support the saving of our environment and social justice causes. In Corporate America he’s passed from CEO to CEO behind closed doors and referred to as “That Magic Coach”… in Spiritual circles he’s known for breakthrough money manifestation and referred to as “The Money Mystic” who creates rainmakers for organizations. Past clients include Hewlett Packard, The Gap, Levi Strauss, the United States Airforce, Guidant, Broadview, Intel Corp., Hunt Oil, Exar, BOSCH, The Global Fund for Women, Capricorn Investments, Superior Court Judges, and numerous high profile entrepreneurs. We talk all about Eneagrams in this Inspired Conversation. You're going to fall deep and want to know even more about yourself once you hear the power of knowing your score. Learn. Create. Thrive. www.InspiredConversations.net www.AmySchuber.com

In this episode, Devi chats with Ben Saltzman about "The Power of Enneagram in Business". Ben is an igniter of human potential, the coaches coach, an internationally known World Class facilitator, shadow dancer, fortune 500 leadership trainer, coach to spiritually minded multi-millionaire entrepreneurs, and designer of the year-long Relational Mastery Course for Emerging Leaders. Ben has a Masters Degree in Organizational Development from John F. Kennedy University where he teaches regularly, he taught seminars in the Enneagram and Transformational Coaching at the Institute of Transpersonal Psychology, and co-founded the Israeli Enneagram Center in Tel Aviv, Israel where he facilitates the master level classes. Thousands of people from many countries have been through his seminars in the past 20 years. His coaching clients have raised hundreds of millions of dollars for projects that support the environment and social justice causes. In corporate America, he’s passed from CEO to CEO behind closed doors and referred to as “That Magic Coach” Past clients include: Hewlett Packard, The Gap, Levi Strauss, the United States Airforce, Guidant, Broadview, Intel Corp., Hunt Oil, Exar, BOSCH, The Global Fund for Women, Capricorn Investments, and numerous high profile entrepreneurs. Devi and Ben discuss: Ben’s spiritual journey The definition of “Enneagram” Keeping your options open and learning how to commit The background of spiritual evolution The mystical mystery of spiritual evolution The best modalities for the spiritual evolution type Discovering your type 9 different personality types Having a creative and authentic relationship Example of a type 5 client Characteristics of each type Observing yourself doing what you do Witnessing your Enneagram type Cultivation of your weakness Definition of “shadow work” The similarity of “shadows” and “Enneagram type” Building trust and connection Bringing society together The “Enneagram ripple effect” and more… Connect with Ben @ touchedandtransformed.com

Twenty years ago, Maria Sainz faced an unusual fork in her career road. She chose wisely, building an esteemed career in Medtech that included senior leadership at Guidant and CEO posts at three Medtech start-ups. In this Medtech Talk Podcast, Sainz recounts the magic of Guidant, the merger with Boston Scientific, and her rewarding – and sometimes challenging – move into being a Medtech start-up CEO. She also talks about her current company’s post-approval trial strategy.

Retrouvez Le Son de l'Image avec Simon Buisson du 23 novembre 2018 sur RTL.fr.

Alex Tilson, Founder & CEO, Loma Vista Medical & Neptune Medical Alex Tilson is the founder and CEO of Neptune Medical. Alex has spent the last twenty- five years leading high performance teams that build innovative, world-class products, including solar powered race vehicles (Stanford University, across the U.S. 2x and across Australia), film industry animatronic special effects (Edge Innovations (‘Free Willy' and ‘Anaconda')), surgical robotics (Intuitive Surgical), products for interventional cardiology (Guidant), implantable coronary devices (Converge Medical), extended wear hearing aids (InSound Medical), and high performance composite medical balloons (Loma Vista Medical). He is a Stanford mechanical engineer and earned an MBA from Harvard. Alex is an avid cyclist (nine major tours, including across Asia and 4x across North America), and a competitive distance runner (Olympic Trial marathoner and former American 50k record holder (http://www.hogue.com/svclassic/index2002.html)).

A Cardiovascular Physician Assistant since 1997, the focus of Kollpainter’s career has been on endoscopic vessel harvest and post-operative patient care. Since its inception, Kollpainter has been involved with all aspects of endoscopic vessel harvest. He has been named a Diamond level harvester by Guidant, having one of the largest known harvesting experiences. He has been a contributor at the corporate level as a Clinical and Teaching Consultant as well as being an Advisory Board Member since 2002. Kollpainter most notably contribution is that of the Maquet HEMOPRO cut-and-seal technology. It has been his honor to have been one of the handful of CVPA's to teach endoscopic harvest techniques extensively throughout the United States, Europe, and India. Kollpainter has been involved with bedside ultrasound since 2005, receiving credentials as a Diagnostic Medical Sonographer in 2008.

In this episode, Dr. Heidi interviews Ben Saltzman about the Nine Enneagram types and how they respond differently to the changing digital landscape. They dig deep into how types correspond with the digital self, and how they can shift in the changing landscape. From Dr. Heidi’s Type One to Ben’s Type Seven, there are great perspectives on how our lens on the world can impact our ability to handle change. Ben Saltzman is The Coach's Coach, a Spiritual Maverick, Relational Wizard, Enneagram devotee, internationally known seminar facilitator, fortune 500 trainer, popular consultant to entrepreneurial multi-millionaires. Ben has a Masters Degree in Organizational Development from John F. Kennedy University where he teaches regularly. He taught seminars in The Enneagram and Transformational Coaching at the Institute of Transpersonal Psychology, and co-founded the Israeli Enneagram Center in Tel Aviv, Israel where he teaches the master level classes. He is the creator of the Enneagram and Shadow Coach Training Program and teaches facilitation skills to the practitioners at the 3000 member church Inner Light Ministries. Ben currently teaches a year long program titled “Relational Mastery to Build Trust, Open Hearts, and Inspire Action” which is a psycho-spiritual transformational program. Past clients include: Hewlett Packard, The Gap, Levi Strauss, Sun Microsystems, United States Air Force, Guidant, Broadview, Intel Corp., University of California Santa Cruz, Hunt Oil, Exar, BOSCH, The Global Fund for Women, Capricorn Investments, ASI, and numerous high profile entrepreneurs. website: www.touchedandtransformed.comEnneagram assessment: http://bit.ly/enneagram-assess  This episode is brought to you by my wellbeing tech of choice, Oska Pulse. It has helped relieve my chronic pain caused by Lyme disease so that I can get back to work, and life in general. Oska Pulse is a Pain Relief and Recovery Device using Pulsed Electromagnetic Field Therapy (PEMF). It creates an electromagnetic field that pulsates while it modulates the damaged cells to squeeze the toxins out and opens the cells to allow nutrients (potassium, sodium and magnesium) to flow into the cell. The Oska Pulse puts the damaged cells in the best situation to repair themselves and then replicates the electrical signals your body creates to fix the damaged cells. Click here to get yours today with my Ambassador discount. Or enter 2BU as a discount code at OskaWellness.com.

"Success can be defined in a multitude of ways but in franchising, success is about being the right kind of person who makes the right kinds of decisions that help those in their sphere of influence become the right kind of people." - Jerry Darnell  This week on Franchise Today co-hosts, Stan Friedman and Paul Segreto welcome as their guest, Jerry Darnell, CEO of Jerry Darnell & Associates. Often referred to as the “Mayor of Franchising” and recognized by many, as the creator of franchise “Discovery Days,” Jerry has worked through an illustrious 35 year-long franchising career that has seen him build new franchise division infrastructures for multi-billion dollar companies like the Medicine Shoppe and develop successful franchise programs for such well-known brands as Physicians Weight Loss Centers and Sterling Optical.  Perhaps best known for his years as a consultant to MAACO Founder Tony Martino, or as a senior executive with Guidant, Benetrends or Bob Gappa’s Management 2000, there is nobody in franchising who has served so long, brought so many people together and can still remember each and every second of his amazing 35 year-long career, as if it all just happened yesterday.  Franchise Today airs LIVE Wednesdays at 11AM CT / 12PM ET with on-demand access on iTunes.

Dr Joe Smith is the Chief Medical & Science Officer at the West Health Institute and President of The West Health Policy Center. Originally trained in Medical Engineering and Physics he then pursued his MD training at Harvard. After 20 years as a practicing Electrophysiologist he became Chief Medical Officer for Guidant and Boston Scientific's Cardiac Rhythm Management Division. Named as one of the "Twenty People Who Make Healthcare Better' he also serves as faculty advisor to the University of Southern California, Johns Hopkins, Harvard & MIT and The Wellcome Trust. In this discussion we delve deep into the motivations to pursue a career in medicine, how the arc of your career can take many paths and the skills that physicians are valued most for in roles outside of traditional clinical care.  If you enjoyed this episode please ‘Subscribe‘ on iTunes or Stitcher.   Enjoy!   Selected Show Notes:   West Health Institute, La Jolla, California. West Health Policy Institute, Washington DC.  Meditations by Marcus Aurelius.  The Youngest Science: Notes of a Medicine-Watcher by Lewis Thomas. Twitter:  @JoeSmithMD

what past experiences led to your success? Question everything. Asking questions to world leaders in art, business, music, and technology. T.A.'s bio: I am a founder of Rival IQ - the best way to analyze and monitor your competitive landscape. Focused on active online marketers who want to get ahead, Rival IQ saves you time and delivers key insights about your competitors across their key marketing channels (web, search, social…). Try a sample “landscape” here for major car brands. I was previously VP of Product Strategy at Blackberry (formally Research in Motion), focused on BBM (Blackberry Messenger), social applications (Facebook, LinkedIn, Twitter, Foursquare…) as well as the native Contacts apps after Blackberry bought my last company, Gist. I was the founder of Gist.com, a social address book sold to Blackberry in February 2011, as well as Jump2Go and 3 other web based companies. I am on the board of Full Contact and Guidant. I am an active advisor to startup companies including Creative Live, Zooppa and EveryMove. I also spent 4 years at Microsoft in various roles on Exchange and Mobile Service Delivery Platforms. I like B2B and mobile stuff! I am a new, but active angel investor and have made investments in Creative Live, Inside Social, Everpath, Heapsylon, Skedadle as well as Founders Co-op, FG Angels and SKV. I am looking to do more so connect with me here. I like sharing my experience and ideas, so I spend lots of time at Startup Weekend (on the board) and Techstars (active mentor), Buerk Center for Entrepreneurship at the University of Washington (on the board) as well as Lake Washington Girls Middle School. I learn by mentoring, coaching and teaching. Prior to my startup activity, I was a professional sailor and competed in 2 America's Cups (won one, lost one) and the Whitbread Round the World race (now called the Volvo Ocean Race). I am married to Teresa, a wonderful and creative woman and father of Ray, a smart, caring and active daughter! When I am not working, I like to run and bike long distances and swim at 1/2 the pace I did in college.

I meet so many people every year with great ideas for small businesses, but not enough capital to get them started. Financing your small business doesn't have to be a scary process anymore. I am SO excited to welcome today's guest, Co-Founder and President of Guidant Financial, Jeremy Ames. Jeremy's entrepreneurial endeavors have given him diversebusiness experience launching and growing a number of companies in the realestate, online media, financing and personal service sectors.Jeremy understands the unique challenges of Guidant'score small business customers well. Along with his start-up experience, he is athree-time franchisee. Jeremy's been honored as one of the Puget Sound Business Journal's 40under 40 and as the national winner of the Young Entrepreneur of the Year awardgiven by the Small Business Administration (SBA). He's also a former boardmember of the Seattle Chapter of The Entrepreneurs' Organization and Togetherfor Tranfsormation. For more information about the Show and Mat and Mark, visit www.refreshyourwealth.com.

I meet so many people every year with great ideas for small businesses, but not enough capital to get them started. Financing your small business doesn't have to be a scary process anymore. I am SO excited to welcome today's guest, Co-Founder and President of Guidant Financial, Jeremy Ames.  Jeremy's entrepreneurial endeavors have given him diverse business experience launching and growing a number of companies in the real estate, online media, financing and personal service sectors. Jeremy understands the unique challenges of Guidant's core small business customers well. Along with his start-up experience, he is a three-time franchisee. Jeremy's been honored as one of the Puget Sound Business Journal's 40 under 40 and as the national winner of the Young Entrepreneur of the Year award given by the Small Business Administration (SBA). He's also a former board member of the Seattle Chapter of The Entrepreneurs' Organization and Together for Tranfsormation.  The show will broadcast Tuesday, December 30th at 11am PST / 2 EST. You can call in and listen LIVE on the road at 646-200-4285.

Manny Villafanna, founder, St. Jude Medical, Guidant and Kip's Bay Medical, joins medtech CEOs Brian Concannon, Duane DeSisto, Charles Carignan and Carmichael Roberts for a discussion on leadership.

La Liberté guidant le peuple: un tableau devenu icône de la république triomphante. Pourtant telle n'a jamais été l'intention de Delacroix, dandy-conservateur effrayé par les émeutes populaires. La fortune de l'oeuvre reposerait-elle sur un immense contresens ? Cette vidéo peut être utilisée à domicile et en classe. Plus d'infos et de contenus sur www.canal-educatif.fr. Tous droits réservés.

Guidant Group, Inc. featured on 21st Century Television